Advertisement

Pathologie pp 631-712 | Cite as

Schilddrüse

  • Kurt Werner SchmidEmail author
  • Sien-Yi Sheu-Grabellus
Chapter
Part of the Pathologie book series (PATHOL)

Zusammenfassung

Dieses große Kapitel fasst die nichtneoplastischen und neoplastischen Erkrankungen der Schilddrüse zusammen, wobei auf der Basis der WHO-Klassifikation detailliert in Bild und Text auf die morphologischen Erscheinungsformen eingegangen wird. Gleichzeitig werden die wichtigsten Informationen zu Epidemiologie, Genetik und Biologie zusammengestellt.

Literatur

  1. 1.
    Adeniran AJ, Zhu Z, Gandhi M, Steward DL, Fidler JP, Giordano TJ, Biddinger PW, Nikiforov YE (2006) Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 30:216–222PubMedGoogle Scholar
  2. 2.
    Adnan Z, Arad E, Dana J, Shendler Y, Baron E (2013) Simultaneous occurrence of medullary and papillary thyroid microcarcinomas: a case series and review of the literature. J Med Case Rep 7:26PubMedCentralPubMedGoogle Scholar
  3. 3.
    Agaimy A, Hahn T, Schroeder J, Elhag A (2012) Follicular thyroid adenoma dominated by spindle cells: report of two unusual cases and literature review. Int J Clin Exp Pathol 5:143–151PubMedGoogle Scholar
  4. 4.
    Agaimy A, Erlenbach-Wünsch K, Konukiewitz B, Schmitt AM, Rieker RJ, Vieth M, Kiesewetter F, Hartmann A, Zamboni G, Perren A, Klöppel G (2013) ISL1 expression is not restricted to pancreatic well differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrahepatic origin. Mod Pathol 26:995–1003PubMedGoogle Scholar
  5. 5.
    Ahmed R, Al-Shaikh S, Akhtar M (2012) Hashimoto thyroiditis: a century later. Adv Anat Pathol 19:181–186PubMedGoogle Scholar
  6. 6.
    Albores-Saavedra J, Monforte H, Nadji M, Morales AR (1988) C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol 19:795–799PubMedGoogle Scholar
  7. 7.
    Albores-Saavedra J, Gould E, Vardaman C, Vuitch F (1991) The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum Pathol 22:1195–1205PubMedGoogle Scholar
  8. 8.
    Albores-Saavedra J, Carrick K (2004) Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol 15:297–305PubMedGoogle Scholar
  9. 9.
    Alexander CB, Herrera GA, Jaffe K, Yu H (1985) Black thyroid: clinical manifestations, ultrastructural findings, and possible mechanisms. Hum Pathol 16:72–78PubMedGoogle Scholar
  10. 10.
    Alzouebi M, Goepel JR, Horsman JM, Hancock BW (2012) Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre. Int J Oncol 40:2075–2080PubMedGoogle Scholar
  11. 11.
    Amal B, El Fatemi H, Souaf I, Moumna K, Affaf A (2013) A rare primary tumor of the thyroid gland: report a new case of leiomyosarcoma and literature review. Diagn Pathol 8:36PubMedCentralPubMedGoogle Scholar
  12. 12.
    Apel RL, Ezzat S, Bapat BV, Pan N, LiVolsi VA, Asa SL (1995) Clonality of thyroid nodules in sporadic goiter. Diagn Mol Pathol 4:113–121PubMedGoogle Scholar
  13. 13.
    Arora N, Scognamiglio T, Zhu B, Fahey TJ 3rd (2008) Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg 32:1237–1246PubMedGoogle Scholar
  14. 14.
    Asa SL (2004) My approach to oncocytic tumours of the thyroid. J Clin Pathol 57:225–232PubMedCentralPubMedGoogle Scholar
  15. 15.
    Bahn RS (2010) Graves’ ophthalmopathy. N Engl J Med 362:726–738PubMedCentralPubMedGoogle Scholar
  16. 16.
    Baloch ZW, LiVolsi VA (1999) Post fine-needle aspiration histologic alterations of thyroid revisited. Am J Clin Pathol 112:311–316PubMedGoogle Scholar
  17. 17.
    Baloch ZW, LiVolsi VA (2000) Warthin-like papillary carcinoma of the thyroid. Arch Pathol Lab Med 124:1192–1195PubMedGoogle Scholar
  18. 18.
    Baloch ZW, LiVolsi VA (2000) Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol 13:861–865PubMedGoogle Scholar
  19. 19.
    Baloch ZW, Solomon AC, LiVolsi VA (2000) Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: report of nine cases. Mod Pathol 13:802–807PubMedGoogle Scholar
  20. 20.
    Baloch ZW, Puttaswamy K, Brose M, LiVolsi VA (2006) Lack of BRAF mutations in hyalinizing trabecular neoplasm. Cytojournal 3:17PubMedCentralPubMedGoogle Scholar
  21. 21.
    Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ (2008) Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:425–437PubMedGoogle Scholar
  22. 22.
    Barclay ML, Brownlie BE, Turner JG, Wells JE (1994) Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol (Oxf) 40:759–764Google Scholar
  23. 23.
    Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297PubMedGoogle Scholar
  24. 24.
    Baschieri L, Castagna M, Fierabracci A, Antonelli A, Del Guerra P, Squartini F (1989) Distribution of calcitonin- and somatostatin-containing cells in thyroid lymphoma and in Hashimoto’s thyroiditis. Appl Pathol 7:99–104PubMedGoogle Scholar
  25. 25.
    Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, Salvatore G, Chiappetta G, Pacini F, Elisei R, Miccoli P, Pinchera A, Fusco A, Santoro M (2002) Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. Am J Pathol 160:247–254PubMedCentralPubMedGoogle Scholar
  26. 26.
    Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, Cailleux AF, Lumbroso JD, Parmentier C, Schlumberger M (1998) Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83:553–559PubMedGoogle Scholar
  27. 27.
    Beerman H, Rigaud C, Bogomoletz WV, Hollander H, Veldhuizen RW (1990) Melanin production in black medullary thyroid carcinoma (MTC). Histopathology 16:227–233PubMedGoogle Scholar
  28. 28.
    Berger SA, Zonszein J, Villamena P, Mittman N (1983) Infectious diseases of the thyroid gland. Rev Infect Dis 5:108–122PubMedGoogle Scholar
  29. 29.
    Bergholm U, Bergström R, Ekbom A (1997) Long-term follow-up of patients with medullary carcinoma of the thyroid. Cancer 79:132–138PubMedGoogle Scholar
  30. 30.
    Bernstein JI, Virk R, Hui P, Prasad A, Westra WH, Tallini G, Adeniran AJ, Udelsman R, Sasaki CT, Roman S, Sosa JA, Prasad ML (2013) Tall cell variant of papillary thyroid microcarcinoma: clinicopathological features with BRAFV600E mutational analysis. Thyroid 23:1525–1531PubMedGoogle Scholar
  31. 31.
    Blasius S, Edel G, Grünert J, Böcker W, Schmid KW (1994) Anaplastic thyroid carcinoma with osteosarcomatous differentiation. Pathol Res Pract 190:507–510PubMedGoogle Scholar
  32. 32.
    Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid KW, Broelsch CE (2004) Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid 14:468–470PubMedGoogle Scholar
  33. 33.
    Bockhorn M, Sheu SY, Frilling A, Molmenti E, Schmid KW, Broelsch CE (2005) Paraganglioma-like medullary thyroid carcinoma: a rare entity. Thyroid 15:1363–1367PubMedGoogle Scholar
  34. 34.
    Bondeson L, Ljungberg O (1981) Occult thyroid carcinoma at autopsy in Malmö, Sweden. Cancer 47:319–323PubMedGoogle Scholar
  35. 35.
    Boos LA, Dettmer M, Schmitt A, Rudolph T, Steinert H, Moch H, Sobrinho-Simões M, Komminoth P, Perren A (2013) Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas – a TMA-based study of 226 cases. Histopathology 63:234–241PubMedGoogle Scholar
  36. 36.
    Booya F, Sebo TJ, Kasperbauer JL, Fatourechi V (2006) Primary squamous cell carcinoma of the thyroid: report of ten cases. Thyroid 16:89–93PubMedGoogle Scholar
  37. 37.
    Brauckhoff M, Machens A, Hess S, Lorenz K, Gimm O, Brauckhoff K, Sekulla C, Dralle H (2008) Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis. Surgery 144:1044–1050PubMedGoogle Scholar
  38. 38.
    Brauer VF, Scholz GH, Neumann S, Lohmann T, Paschke R, Koch CA (2004) RET germline mutation in codon 791 in a family representing 3 generations from age 5 to age 70 years: should thyroidectomy be performed? Endocr Pract 10:5–9PubMedGoogle Scholar
  39. 39.
    Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD (2008) The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 93:504–515PubMedGoogle Scholar
  40. 40.
    Brzeziańska E, Pastuszak-Lewandoska D, Lewiński A (2007) Rearrangements of NTRK1 oncogene in papillary thyroid carcinoma. Neuro Endocrinol Lett 28:221–229PubMedGoogle Scholar
  41. 41.
    Bülow C, Bülow S (1997) Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group. Int J Colorectal Dis 12:240–242PubMedGoogle Scholar
  42. 42.
    Burke BA, Johnson D, Gilbert EF, Drut RM, Ludwig J, Wick MR (1987) Thyrocalcitonin-containing cells in the Di George anomaly. Hum Pathol 18:355–360PubMedGoogle Scholar
  43. 43.
    Burt AD, MacGuire J, Lindop GB, Browne MK (1987) Mixed follicular-parafollicular carcinoma of the thyroid. Scott Med J 32:50–51PubMedGoogle Scholar
  44. 44.
    Cakir M, Altunbas H, Balci MK, Karayalcin U, Karpuzoglu G (2002) Medullary thyroid carcinoma, follicular variant. Endocr Pathol 13:75–79PubMedGoogle Scholar
  45. 45.
    Cameselle-Teijeiro J, Chan JK (1999) Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol 12:400–411PubMedGoogle Scholar
  46. 46.
    Cameselle-Teijeiro J (2011) Uncommon tumors of the thyroid gland. Int J Surg Pathol 18:205–208Google Scholar
  47. 47.
    Cameselle-Teijeiro J, Ferreira R, Caramés N, Abdulkader I, Máximo V, Soares P, Sobrinho-Simões M (2012) Absence of the BRAF and the GRIM-19 mutations in oncocytic (Hürthle cell) solid cell nests of the thyroid. Am J Clin Pathol 137:612–618PubMedGoogle Scholar
  48. 47a.
    Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676–690Google Scholar
  49. 48.
    Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma”. Am J Surg Pathol 8:655–668PubMedGoogle Scholar
  50. 49.
    Carcangiu ML, Steeper T, Zampi G, Rosai J (1985) Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 83:135–158PubMedGoogle Scholar
  51. 50.
    Carcangiu ML, Bianchi S (1989) Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol 13:1041–1049PubMedGoogle Scholar
  52. 51.
    Carney JA, Ryan J, Goellner JR (1987) Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 11:583–591PubMedGoogle Scholar
  53. 52.
    Carney JA, Hirokawa M, Lloyd RV, Papotti M, Sebo TJ (2008) Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am J Surg Pathol 32:1877–1889PubMedGoogle Scholar
  54. 53.
    Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, de Vieira Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M (2006) PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 91:213–220PubMedGoogle Scholar
  55. 54.
    Cavaco BM, Batista PF, Martins C, Banito A, do Rosário F, Limbert E, Sobrinho LG, Leite V (2008) Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Endocr Relat Cancer 15:207–215PubMedGoogle Scholar
  56. 55.
    Chan JK, Tse CC (1989) Solid cell nest-associated C-cells: another possible explanation for ″C-cell hyperplasia″ adjacent to follicular cell tumors. Hum Pathol 20:498–499PubMedGoogle Scholar
  57. 56.
    Chan JK, Rosai J (1991) Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol 22:349–367PubMedGoogle Scholar
  58. 57.
    Chan JKC (2007) Tumors of the thyroid and parathyroid glands. In: Fletcher CDM (Hrsg) Diagnostic Histopathology of Tumors, 3. Aufl. Bd. 2. Churchill Livingstone, London, S 997–1079 (Chapter 18)Google Scholar
  59. 58.
    Charkes ND (2006) On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid 16:181–186 (Erratum in: Thyroid 16: 520)PubMedGoogle Scholar
  60. 59.
    Chazenbalk GD, Pichurin P, Chen CR, Latrofa F, Johnstone AP, McLachlan SM, Rapoport B (2002) Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest 110:209–217PubMedCentralPubMedGoogle Scholar
  61. 60.
    Chen H, Nicol TL, Zeiger MA, Dooley WC, Ladenson PW, Cooper DS, Ringel M, Parkerson S, Allo M, Udelsman R (1998) Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann Surg 227:542–546PubMedCentralPubMedGoogle Scholar
  62. 61.
    Chertok Shacham E, Ishay A, Irit E, Pohlenz J, Tenenbaum-Rakover Y (2012) Minimally invasive follicular thyroid carcinoma developed in dyshormonogenetic multinodular goiter due to thyroid peroxidase gene mutation. Thyroid 22:542–546PubMedGoogle Scholar
  63. 62.
    Chetty R (1990) Hürthle cell medullary carcinomas of the thyroid gland. S Afr J Surg 28:95–97PubMedGoogle Scholar
  64. 63.
    Chetty R (2011) Follicular patterned lesions of the thyroid gland: a practical algorithmic approach. J Clin Pathol 64:737–741PubMedGoogle Scholar
  65. 64.
    Cheuk W, Jacobson AA, Chan JK (2000) Spindle epithelial tumor with thymus-like differentiation (SETTLE): a distinctive malignant thyroid neoplasm with significant metastatic potential. Mod Pathol 13:1150–1155PubMedGoogle Scholar
  66. 65.
    Cheung CC, Boerner SL, MacMillan CM, Ramyar L, Asa SL (2000) Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol 24:1622–1626PubMedGoogle Scholar
  67. 66.
    Cheung L, Messina M, Gill A, Clarkson A, Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R, Robinson BG (2003) Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 88:354–357PubMedGoogle Scholar
  68. 67.
    Chiosea S, Nikiforova M, Zuo H, Ogilvie J, Gandhi M, Seethala RR, Ohori NP, Nikiforov YE (2009) A novel complex BRAF mutation detected in a solid variant ofpapillary thyroid carcinoma. Endocr Pathol 20:122–126PubMedGoogle Scholar
  69. 68.
    Chong GC, Beahrs OH, Sizemore GW, Woolner LH (1975) Medullary carcinoma of the thyroid gland. Cancer 35:695–704PubMedGoogle Scholar
  70. 69.
    Chow EJ, Friedman DL, Stovall M, Yasui Y, Whitton JA, Robison LL, Sklar CA (2009) Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 53:432–437PubMedCentralPubMedGoogle Scholar
  71. 70.
    Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH (2003) Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer 98:31–40PubMedGoogle Scholar
  72. 71.
    Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN, Rabes HM, Fagin JA, Nikiforov YE (2005) Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115:94–101PubMedCentralPubMedGoogle Scholar
  73. 72.
    Ciampi R, Giordano TJ, Wikenheiser-Brokamp K, Koenig RJ, Nikiforov YE (2007) HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma. Endocr Relat Cancer 14(2):445–452PubMedGoogle Scholar
  74. 73.
    Clerici T, Kolb W, Beutner U, Bareck E, Dotzenrath C, Kull C, Niederle B, Kaserer K, Perren A, Schmid KW, Köberle-Wührer R, Wenzl E, Asari R, Klinge U, Müller G, Kroell KP, Blankenburg C, Voss H, Cupisti K, Witte J, Knoefel WT, Simon D, Lienenlüke RH, Vorländer C, Wacha H, Schabram J, Lorenz K, Dralle H, Wojciechowski B, Kussmann J, Weber Y, Schürmann G, Goretzki PE, Ulitzer H, Eberle A, Mayer M, Stabenow R, Stegmaier C, Bühlmann R, Schlumpf R, Triponez F, Ess SM (2010) Diagnosis and treatment of small follicular thyroid carcinomas. Br J Surg 97:839–844PubMedGoogle Scholar
  75. 74.
    Coli A, Bigotti G, Zucchetti F, Negro F, Massi G (2000) Papillary carcinoma in amyloid goitre. J Exp Clin Cancer Res 19:391–394PubMedGoogle Scholar
  76. 75.
    Collini P, Sampietro G, Rosai J, Pilotti S (2003) Minimally invasive (encapsulated) follicular carcinoma of the thyroid gland is the low-risk counterpart of widely invasive follicular carcinoma but not of insular carcinoma. Virchows Arch 442:71–76PubMedGoogle Scholar
  77. 76.
    Collini P, Sampietro G, Pilotti S (2004) Extensive vascular invasion is a marker of risk of relapse in encapsulated non-Hürthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up. Histopathology 44:35–39PubMedGoogle Scholar
  78. 77.
    Collins J, Gough S (2002) Autoimmunity in thyroid disease. Eur J Nucl Med Mol Imaging 29(2):417–S424Google Scholar
  79. 78.
    Coltrera MD (1999) Primary T-cell lymphoma of the thyroid. Head Neck 21:160–163PubMedGoogle Scholar
  80. 79.
    Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedGoogle Scholar
  81. 80.
    Corvi R, Martinez-Alfaro M, Harach HR, Zini M, Papotti M, Romeo G (2001) Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization. Lab Invest 81:1639–1645PubMedGoogle Scholar
  82. 81.
    Costinean S, Balatti V, Bottoni A, Old M, Croce C, Wakely PE Jr (2012) Primary intrathyroidal paraganglioma: histopathology and novel molecular alterations. Hum Pathol 43:2371–2375PubMedGoogle Scholar
  83. 82.
    Couto JP, Prazeres H, Castro P, Lima J, Máximo V, Soares P, Sobrinho-Simões M (2009) How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer. J Clin Pathol 62:414–421PubMedGoogle Scholar
  84. 83.
    Dahlgren M, Khosroshahi A, Nielson GP, Deshpande V, Stone JH (2010) Riedel’s Thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arth Care Res 62:1312–1318Google Scholar
  85. 84.
    D’Antonio A, Addesso M, De Dominicis G, Boscaino A, Liguori G, Nappi O (2007) Mucinous carcinoma of thyroid gland. Report of a primary and a metastatic mucinous tumour from ovarian adenocarcinoma with immunohistochemical study and review of literature. Virchows Arch 451:847–851PubMedGoogle Scholar
  86. 85.
    D’Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH (2004) Follicular thyroid carcinoma: histology and prognosis. Cancer 100:1123–1129PubMedGoogle Scholar
  87. 86.
    Davies L, Welch HG (2006) Increasing incidence of thyroid cancer inthe United States, 1973–2002. JAMA 295:2164–2167PubMedGoogle Scholar
  88. 87.
    De Jong SA, Demeter JG, Jarosz H, Lawrence AM, Paloyan E (1993) Primary papillary thyroid carcinoma presenting as cervical lymphadenopathy: the operative approach to the ″lateral aberrant thyroid″. Am Surg 59:172–176PubMedGoogle Scholar
  89. 88.
    Delbridge L, Parkyn R, Philips J, Barraclough B, Robinson B (2002) Minimally invasive follicular thyroid carcinoma: completion thyroidectomy or not? ANZ J Surg 72:844–845PubMedGoogle Scholar
  90. 89.
    DeLellis RA, May L, Tashjian AH Jr, Wolfe HJ (1978) C-cell granule heterogeneity in man. An ultrastructural immunocytochemical study. Lab Invest 38:263–269PubMedGoogle Scholar
  91. 90.
    DeLellis RA, Wolfe HJ (1981) The pathobiology of the human calcitonin (C)-cell: a review. Pathol Annu 16:25–52Google Scholar
  92. 91.
    DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) WHO histological classification of thyroid and parathyroid tumours. In: World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of Endocrine Organs. IARC Press, LyonGoogle Scholar
  93. 92.
    DeLellis RA, Shin SJ (2006) Immunohistology of Endocrine Tumors. In: Dabbs DJ (Hrsg) Diagnostic Immunohistochemistry. Churchill Livingstone, New York, S 261–300Google Scholar
  94. 93.
    de Lima MA, Dias Medeiros J, Rodrigues Da Cunha L, de Cássia Caldas Pessôa R, Silveira Tavares F, de Fátima Borges M, Marinho EO (2001) Cytological aspects of melanotic variant of medullary thyroid carcinoma. Diagn Cytopathol 24:206–208PubMedGoogle Scholar
  95. 94.
    de Matos PS, Ferreira AP, Ward LS (2006) Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series. Endocr Pathol 17:165–173PubMedGoogle Scholar
  96. 95.
    Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL (2000) Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 24:623–639PubMedGoogle Scholar
  97. 96.
    Desailloud R, Hober D (2009) Viruses and thyroiditis: an update. Virol J 6:5PubMedCentralPubMedGoogle Scholar
  98. 97.
    Deshpande A, Bobhate SK (1995) Squamous cell carcinoma in thyroglossal duct cyst. J Laryngol Otol 109:1001–1004PubMedGoogle Scholar
  99. 98.
    Dettmer M, Schmitt A, Steinert H, Haldemann A, Meili A, Moch H, Komminoth P, Perren A (2011) Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? Am J Surg Pathol 35:1866–1872PubMedGoogle Scholar
  100. 99.
    Dettmer M, Schmitt A, Steinert H, Moch H, Komminoth P, Perren A (2012) Poorly differentiated oncocytic thyroid carcinoma–diagnostic implications and outcome. Histopathology 60:1045–1051PubMedGoogle Scholar
  101. 100.
    de Vries MM, Celestino R, Castro P, Eloy C, Máximo V, van der Wal JE, Plukker JT, Links TP, Hofstra RM, Sobrinho-Simões M, Soares P (2012) RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas. Histopathology 61:833–843PubMedGoogle Scholar
  102. 101.
    Dionigi G, Castano P, Bertolini V, Boni L, Rovera F, Tanda ML, Capella C, Bartalena L, Dionigi R (2007) Simultaneous medullary and papillary thyroid cancer: two case reports. J Med Case Rep 1:133PubMedCentralPubMedGoogle Scholar
  103. 102.
    Dockhorn-Dworniczak B, Franke WW, Schröder S, Czernobilsky B, Gould VE, Böcker W (1987) Patterns of expression of cytoskeletal proteins in human thyroid gland and thyroid carcinomas. Differentiation 35:53–71PubMedGoogle Scholar
  104. 103.
    Dominguez-Malagon H, Delgado-Chavez R, Torres-Najera M, Gould E, Albores-Saavedra J (1989) Oxyphil and squamous variants of medullary thyroid carcinoma. Cancer 63:1183–1188PubMedGoogle Scholar
  105. 104.
    Dralle H, Gimm O, Simon D, Frank-Raue K, Görtz G, Niederle B, Wahl RA, Koch B, Walgenbach S, Hampel R, Ritter MM, Spelsberg F, Heiss A, Hinze R, Höppner W (1998) Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22:744–750PubMedGoogle Scholar
  106. 105.
    Dralle H, Machens A, Lorenz K (2008) Hereditäre Schilddrüsenkarzinome. Chirurg 79:1017–1028PubMedGoogle Scholar
  107. 106.
    Dralle H, Machens A (2012) Primary surgery for differentiated thyroid cancer in the new millennium. J Endocrinol Invest 35:10–15PubMedGoogle Scholar
  108. 107.
    Dralle H, Musholt TJ, Schabram J, Steinmüller T, Frilling A, Simon D, Goretzki PE, Niederle B, Scheuba C, Clerici T, Hermann M, Kußmann J, Lorenz K, Nies C, Schabram P, Trupka A, Zielke A, Karges W, Luster M, Schmid KW, Vordermark D, Schmoll HJ, Mühlenberg R, Schober O, Rimmele H, Machens A (2013) German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e.V. German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg 398:347–375PubMedGoogle Scholar
  109. 108.
    Dube VEJGT (1971) Extreme squamous metaplasia in Hashimoto’s thyroiditis. Cancer 27:434–437PubMedGoogle Scholar
  110. 109.
    Eales JG (1988) The influence of nutritional stage on thyroid function in various vertebrates. Am Zool 20:351–362Google Scholar
  111. 110.
    Elisei R, Cosci B, Romei C, Bottici V, Renzini G, Molinaro E, Agate L, Vivaldi A, Faviana P, Basolo F, Miccoli P, Berti P, Pacini F, Pinchera A (2008) Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 93:682–687PubMedGoogle Scholar
  112. 111.
    Eloy JA, Mortensen M, Gupta S, Lewis MS, Brett EM, Genden EM (2007) Metastasis of uterine leiomyosarcoma to the thyroid gland: case report and review of the literature. Thyroid 17:1295–1297PubMedGoogle Scholar
  113. 112.
    Erovic BM, Kim D, Cassol C, Goldstein DP, Irish JC, Asa SL, Mete O (2012) Prognostic and predictive markers in medullary thyroid carcinoma. Endocr Pathol 23:232–242PubMedGoogle Scholar
  114. 113.
    Evans HL (1984) Follicular neoplasms of the thyroid. A study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosis. Cancer 54:535–540PubMedGoogle Scholar
  115. 114.
    Evans HL (1987) Encapsulated papillary neoplasms of the thyroid. A study of 14 cases followed for a minimum of 10 years. Am J Surg Pathol 11:592–597PubMedGoogle Scholar
  116. 115.
    Fagin JA (2002) Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Mol Endocrinol 16:903–911PubMedGoogle Scholar
  117. 116.
    Falvo L, Giacomelli L, Vanni B, Marzollo A, Guerriero G, De Antoni E (2006) Papillary thyroid carcinoma in thyroglossal duct cyst: case reports and literature review. Int Surg 91:141–146PubMedGoogle Scholar
  118. 117.
    Ferri E, Manconi R, Armato E, Ianniello F (2009) Primary paraganglioma of thyroid gland: a clinicopathologic and immunohistochemical study with review of the literature. Acta Otorhinolaryngol Ital 29:97–102PubMedCentralPubMedGoogle Scholar
  119. 118.
    Fink A, Tomlinson G, Freeman JL, Rosen IB, Asa SL (1996) Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol 9:816–820PubMedGoogle Scholar
  120. 119.
    Fonseca E, Nesland JM, Sobrinho-Simoes M (1997) Expression of stratified epithelial-type cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary carcinomas of the thyroid. Histopathology 31:330–335PubMedGoogle Scholar
  121. 120.
    Franc B, de la Salmonière P, Lange F, Hoang C, Louvel A, de Roquancourt A, Vildé F, Hejblum G, Chevret S, Chastang C (2003) Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. Hum Pathol 34:1092–1100PubMedGoogle Scholar
  122. 121.
    Frank TS, LiVolsi VA, Connor AM (1987) Cytomegalovirus infection of the thyroid in immunocompromised adults. Yale J Biol Med 60:1–8PubMedCentralPubMedGoogle Scholar
  123. 122.
    Frank-Raue K, Machens A, Scheuba C, Niederle B, Dralle H, Raue F (2008) German MEN2 Study Group. Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791. Clin Endocrinol (Oxf) 69:259–263Google Scholar
  124. 123.
    Frank-Raue K, Machens A, Leidig-Bruckner G, Rondot S, Haag C, Schulze E, Lorenz A, Kreissl MC, Dralle H, Raue F, Schmid KW (2013) Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma. Thyroid 23:294–300PubMedGoogle Scholar
  125. 124.
    Franssila KO, Harach HR, Wasenius VM (1984) Mucoepidermoid carcinoma of the thyroid. Cancer 53:1741–1745Google Scholar
  126. 125.
    Franssila KO, Harach HR (1986) Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland. Cancer 58:715–719PubMedGoogle Scholar
  127. 126.
    Fridman MV, Savva NN, Krasko OV, Zborovskaya AA, Mankovskaya SV, Schmid KW, Demidchik YE (2012) Clinical and pathologic features of ″sporadic″ papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus. Thyroid 22:1016–1024PubMedGoogle Scholar
  128. 127.
    Führer D, Holzapfel HP, Wonerow P, Scherbaum WA, Paschke R (1997) Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82:3885–3891PubMedGoogle Scholar
  129. 128.
    Führer D (2001) A nuclear receptor in thyroid malignancy: is PAX8/PPARgamma the Holy Grail of follicular thyroid cancer? Eur J Endocrinol 144:453–456PubMedGoogle Scholar
  130. 129.
    Führer D, Schmid KW (2010) Benigner Schilddrüsenknoten oder Schilddrüsenmalignom? Internist (Berl) 51:611–619Google Scholar
  131. 130.
    Fukunaga FH, Lockett LJ (1971) Thyroid carcinoma in the Japanese in Hawaii. Arch Pathol 92:6–13PubMedGoogle Scholar
  132. 131.
    Fukunaga FH, Yatani R (1975) Geographic pathology of occult thyroid carcinomas. Cancer 36:1095–1099PubMedGoogle Scholar
  133. 132.
    Fukushima M, Ito Y, Hirokawa M, Akasu H, Shimizu K, Miyauchi A (2009) Clinicopathologic characteristics and prognosis of diffuse sclerosing variant of papillary thyroid carcinoma in Japan: an 18-year experience at a single institution. World J Surg 33:958–962PubMedGoogle Scholar
  134. 133.
    Furlan JC, Bedard YC, Rosen IB (2007) Significance of tumor capsular invasion in well-differentiated thyroid carcinomas. Am Surg 73:484–491PubMedGoogle Scholar
  135. 134.
    Gemsenjäger E, Heitz PU, Martina B (1997) Selective treatment of differentiated thyroid carcinoma. World J Surg 21:546–551PubMedGoogle Scholar
  136. 135.
    Ghossein R (2009) Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin. Arch Pathol Lab Med 133:683–691PubMedGoogle Scholar
  137. 136.
    Ghossein R (2009) Update to the College of American Pathologists reporting on thyroid carcinomas. Head Neck Pathol 3:86–93PubMedCentralPubMedGoogle Scholar
  138. 137.
    Ghossein R (2010) Encapsulated malignant follicular cell-derived thyroid tumors. Endocr Pathol 21:212–218PubMedGoogle Scholar
  139. 138.
    Ghossein RA, Rosai J, Heffess C (1997) Dyshormonogenetic goiter: A clinicopathologic study of 56 cases. Endocr Pathol 8:283–292PubMedGoogle Scholar
  140. 139.
    Ghossein RA, Hiltzik DH, Carlson DL, Patel S, Shaha A, Shah JP, Tuttle RM, Singh B (2006) Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer 106:1669–1676PubMedGoogle Scholar
  141. 140.
    Ghossein RA, Katabi N, Fagin JA (2013) Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancer along the spectrum of disease progression. J Clin Endocrinol Metab 98:E1414–1421PubMedGoogle Scholar
  142. 141.
    Gimm O, Krause U, Wessel H, Finke R, Dralle H (1997) Ectopic intrathyroidal thymus diagnosed as a solid thyroid lesion: case report and review of the literature. J Pediatr Surg 32:1241–1243PubMedGoogle Scholar
  143. 142.
    Gimm O, Morrisson CD, Suster S, Komminoth P, Mulligan L, Sweet KM (2004) Multiple endocrine neoplasia type 2. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (Hrsg) World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of Endocrine Organs. IARC Press, Lyon, S 211–217Google Scholar
  144. 143.
    Girelli ME, Nacamulli D, Pelizzo MR, De Vido D, Mian C, Piccolo M, Busnardo B (1998) Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986. Thyroid 8:517–523PubMedGoogle Scholar
  145. 144.
    Godbert Y, Henriques-Figueiredo B, Cazeau AL, Carrat X, Stegen M, Soubeyran I, Bonichon F (2013) A papillary thyroid microcarcinoma revealed by a single bone lesion with no poor prognostic factors. Case Rep Endocrinol 2013:719304PubMedCentralPubMedGoogle Scholar
  146. 145.
    Goldsmith JD, Lai ML, Daniele GM, Tomaszewski JE, LiVolsi VA (2000) Amyloid goiter: report of two cases and review of the literature. Endocr Pract 6:318–323PubMedGoogle Scholar
  147. 146.
    Golshan MM, McHenry CR, de Vente J, Kalajyian RC, Hsu RM, Tomashefski JF (1997) Acute suppurative thyroiditis and necrosis of the thyroid gland: a rare endocrine manifestation of acquired immunodeficiency syndrome. Surgery 121:593–596PubMedGoogle Scholar
  148. 147.
    González-Cámpora R, Fuentes-Vaamonde E, Hevia-Vázquez A, Otal-Salaverri C, Villar-Rodriguez JL, Galera-Davidson H (1998) Hyalinizing trabecular carcinoma of the thyroid gland: report of two cases of follicular cell thyroid carcinoma with hyalinizing trabecular pattern. Ultrastruct Pathol 22:39–46PubMedGoogle Scholar
  149. 148.
    González-González A, Mate LA, Cabra JE (2008) Parasitic thyroid nodule in hashimoto’s thyroiditis. Endocrinol Nutr 55:301–303PubMedGoogle Scholar
  150. 149.
    Goffredo P, Cheung K, Roman SA, Sosa JA (2013) Can minimally invasive follicular thyroid cancer be approached as a benign lesion? A population-level analysis of survival among 1,200 patients. Ann Surg Oncol 20:767–772PubMedGoogle Scholar
  151. 150.
    Goh SG, Chuah KL, Goh HK, Chen YY (2003) Two cases of epithelioid angiosarcoma involving the thyroid and a brief review of non-Alpine epithelioid angiosarcoma of the thyroid. Arch Pathol Lab Med 127:70–73Google Scholar
  152. 151.
    Gordon G, Sparano BM, Kramer AW, Kelly RG, Iatropoulos MJ (1984) Thyroid gland pigmentation and minocycline therapy. Am J Pathol 117:98–109PubMedCentralPubMedGoogle Scholar
  153. 152.
    Greco A, Miranda C, Pierotti MA (2010) Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Mol Cell Endocrinol 321:44–49PubMedGoogle Scholar
  154. 153.
    Grüters-Kieslich A, Karges W, Schmid KW (2011) Kongenitale Schilddrüsenerkrankungen. In: Brabant G, Karges W (Kapitelkoordinatoren) Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Thieme, Stuttgart, Sonderauszugsausgabe Schilddrüsenerkrankungen, S 6–12Google Scholar
  155. 154.
    Guyétant S, Josselin N, Savagner F, Rohmer V, Michalak S, Saint-André JP (2003) C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients. Mod Pathol 16:756–763PubMedGoogle Scholar
  156. 155.
    Harach HR (1985) Histological markers of solid cell nests of the thyroid. With some emphasis on their expression in thyroid ultimobranchial-related tumors. Acta Anat (Basel) 124:111–116Google Scholar
  157. 156.
    Harach HR, Franssila KO, Wasenius VM (1985) Occult papillary carcinoma of the thyroid. A ″normal″ finding in Finland. A systematic autopsy study. Cancer 56:531–538PubMedGoogle Scholar
  158. 157.
    Harach HR (1988) Solid cell nests of the thyroid. J Pathol 155:191–200PubMedGoogle Scholar
  159. 158.
    Harach HR, Bergholm U (1988) Medullary (C cell) carcinoma of the thyroid with features of follicular oxyphilic cell tumours. Histopathology 13:645–656PubMedGoogle Scholar
  160. 159.
    Harach HR, Williams ED (1990) The pathology of granulomatous diseases of the thyroid gland. Sarcoidosis 7:19–27PubMedGoogle Scholar
  161. 160.
    Harach HR, Bergholm U (1992) Small cell variant of medullary carcinoma of the thyroid with neuroblastoma-like features. Histopathology 21:378–380PubMedGoogle Scholar
  162. 161.
    Harach HR, Wilander E, Grimelius L, Bergholm U, Westermark P, Falkmer S (1992) Chromogranin A immunoreactivity compared with argyrophilia, calcitonin immunoreactivity, and amyloid as tumour markers in the histopathological diagnosis of medullary (C-cell) thyroid carcinoma. Pathol Res Pract 188:123–130PubMedGoogle Scholar
  163. 162.
    Harach HR, Bergholm U (1993) Medullary carcinoma of the thyroid with carcinoid-like features. J Clin Pathol 46:113–117PubMedCentralPubMedGoogle Scholar
  164. 163.
    Harach HR (1997) Histogenesis of thyroid C-cell carcinoma. Curr Top Pathol 91:15–20PubMedGoogle Scholar
  165. 164.
    Harb WJ, Sturgis EM (2009) Differentiated thyroid cancer associated with intestinal polyposis syndromes: a review. Head Neck 31:1511–1519PubMedGoogle Scholar
  166. 165.
    Harrer P, Broecker M, Zint A, Schatz H, Zumtobel V, Derwahl M (1998) Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal. J Endocrinol Invest 21:380–385PubMedGoogle Scholar
  167. 166.
    Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ (1992) Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139–1146PubMedGoogle Scholar
  168. 167.
    Haymart MR, Cayo M, Chen H (2009) Papillary thyroid microcarcinomas: big decisions for a small tumor. Ann Surg Oncol 16:3132–139PubMedGoogle Scholar
  169. 168.
    He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A (2005) The role of microRNA genes in papillary thyroid carcinoma. PNAS 102:19075–19080PubMedCentralPubMedGoogle Scholar
  170. 169.
    Hegedüs L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G, Hansen JM (1983) The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 56:260–263PubMedGoogle Scholar
  171. 170.
    Hegedüs L, Karstrup S, Rasmussen N (1986) Evidence of cyclic alterations of thyroid size during the menstrual cycle in healthy women. Am J Obstet Gynecol 155:142–145PubMedGoogle Scholar
  172. 171.
    Hegerova L, Griebeler ML, Reynolds JP, Henry MR, Gharib H (2013) Metastasis to the Thyroid Gland: Report of a Large Series From the Mayo Clinic. Am J Clin Oncol (Epub ahead of print)Google Scholar
  173. 172.
    Hermann M, Tonninger K, Kober F, Furtlehner EM, Schultheis A, Neuhold N (2010) Minimal-invasives follikuläres Schilddrüsenkarzinom. Chirurg 81:627–635PubMedGoogle Scholar
  174. 173.
    Hillman N, Hardisson D, Herranz L, Martinez Olmos MA, Hernandez BJA, Nistal M, Pallardo LF (1997) Hürthle cell tumors. Ann Med Interne 148:434–439Google Scholar
  175. 174.
    Hirokawa M, Carney JA (2000) Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 24:575–578PubMedGoogle Scholar
  176. 175.
    Hofman V, Lassalle S, Bonnetaud C, Butori C, Loubatier C, Ilie M, Bordone O, Brest P, Guevara N, Santini J, Franc B, Hofman P (2009) Thyroid tumours of uncertain malignant potential: frequency and diagnostic reproducibility. Virchows Arch 455:21–33PubMedGoogle Scholar
  177. 176.
    Holm R, Sobrinho-Simões M, Nesland JM, Sambade C, Johannessen JV (1987) Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity? Lab Invest 57:258–268PubMedGoogle Scholar
  178. 177.
    Huang CC, Hsueh C, Liu FH, Chao TC, Lin JD (2011) Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas. Surg Oncol 20:1–6PubMedGoogle Scholar
  179. 178.
    Hunt JL, Baloch ZW, Barnes L, Swalsky PA, Trusky CL, Sesatomi E, Finkelstein S, LiVolsi VA (2002) Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis. Endocr Pathol 13:321–330PubMedGoogle Scholar
  180. 179.
    Hunt J (2005) Understanding the genotype of follicular thyroid tumors. Endocr Pathol 16:311–321PubMedGoogle Scholar
  181. 180.
    Huss LJ, Mendelsohn G (1990) Medullary carcinoma of the thyroid gland: an encapsulated variant resembling the hyalinizing trabecular (paraganglioma-like) adenoma of thyroid. Mod Pathol 3:581–585PubMedGoogle Scholar
  182. 181.
    Hussong JW, Perkins SL, Schnitzer B, Hargreaves H, Frizzera G (1999) Extramedullary plasmacytoma. A form of marginal zone cell lymphoma? Am J Clin Pathol 111:111–116PubMedGoogle Scholar
  183. 182.
    Ikeda T, Satoh M, Azuma K, Sawada N, Mori M (1998) Medullary thyroid carcinoma with a paraganglioma-like pattern and melanin production: a case report with ultrastructural and immunohistochemical studies. Arch Pathol Lab Med 122:555–558PubMedGoogle Scholar
  184. 183.
    Isaacson PG (1997) Lymphoma of the thyroid gland. Curr Top Pathol 91:1–14PubMedGoogle Scholar
  185. 184.
    Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2005) Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29:917–920PubMedGoogle Scholar
  186. 185.
    Ito Y, Miyauchi A (2007) A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab 3:240–248PubMedGoogle Scholar
  187. 186.
    Iwasaki H, Matsumoto A, Ito K, Kure Y, Suzuki A, Sugino K, Ozaki O, Noh J (1990) Prediction of distant metastasis in follicular adenocarcinoma of the thyroid. World J Surg 14:425–429PubMedGoogle Scholar
  188. 187.
    Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I (2011) Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer 117:4439–4446PubMedCentralPubMedGoogle Scholar
  189. 188.
    Iyer S, Bahn R (2012) Immunopathogenesis of Graves’ ophthalmopathy: the role of the TSH receptor. Best Pract Res Clin Endocrinol Metab 26:281–289PubMedCentralPubMedGoogle Scholar
  190. 189.
    Janzer RC, Weber E, Hedinger C (1979) The relation between solid cell nests and C cells of the thyroid gland: an immunohistochemical and morphometric investigation. Cell Tissue Res 197:295–312PubMedGoogle Scholar
  191. 190.
    Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R (2004) Radiotherapy-induced thyroid disorders. Cancer Treat Rev 30:369–384PubMedGoogle Scholar
  192. 191.
    Jochum W, Padberg BC, Schröder S (1994) Lymphoepitheliales Karzinom der Schilddrüse. Pathologe 15:361–365PubMedGoogle Scholar
  193. 192.
    Jones JD, Pittman DL, Sanders LR (1985) Necrosis of thyroid nodules after fine needle aspiration. Acta Cytol 29:29–32PubMedGoogle Scholar
  194. 193.
    Kahaly G, Dralle H, Mann K, Reiners C (2011) Autoimmunthyreopathien. In: Brabant G, Karges W (Kapitelkoordinatoren) Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Thieme, Stuttgart, Sonderauszugsausgabe Schilddrüsenerkrankungen, S 12–22Google Scholar
  195. 194.
    Karger S, Weidinger C, Krause K, Sheu SY, Aigner T, Gimm O, Schmid KW, Dralle H, Führer D (2009) FOXO3a: a novel player in thyroid carcinogenesis? Endocr Relat Cancer 16:189–199PubMedGoogle Scholar
  196. 195.
    Karges W (2005) Klinische und molekulare Genetik des Schilddrüsenkarzinoms. Onkologe 11:20–28Google Scholar
  197. 196.
    Karges W (2010) Kalzitoninbestimmung zur Frühdiagnose des medullären Schilddrüsenkarzinoms. Chirurg 81:620–626PubMedGoogle Scholar
  198. 197.
    Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Vierhapper H, Haas OA, Niederle B (1998) C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 22:722–728PubMedGoogle Scholar
  199. 198.
    Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Haas OA, Vierhapper H, Niederle B (2001) Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol 25:1245–1251PubMedGoogle Scholar
  200. 199.
    Katoh R, Jasani B, Williams ED (1989) Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrastructural studies. Histopathology 15:211–224PubMedGoogle Scholar
  201. 200.
    Kawahara E, Nakanishi I, Terahata S, Ikegaki S (1988) Leiomyosarcoma of the thyroid gland. A case report with a comparative study of five cases of anaplastic carcinoma. Cancer 62:2558–2563PubMedGoogle Scholar
  202. 201.
    Kim WG, Gong G, Kim EY, Kim TY, Hong SJ, Kim WB, Shong YK (2010) Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental. Clin Endocrinol (Oxf) 72:256–263Google Scholar
  203. 202.
    Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454–1457PubMedGoogle Scholar
  204. 203.
    Kimura N, Nakazato Y, Nagura H, Sasano N (1990) Expression of intermediate filaments in neuroendocrine tumors. Arch Pathol Lab Med 114:506–510PubMedGoogle Scholar
  205. 204.
    Kodama T, Fujino M, Endo Y, Obara T, Fujimoto Y, Oda T, Wada T (1980) Identification of carcinoembryonic antigen in the C-cell of the normal thyroid. Cancer 45:98–101PubMedGoogle Scholar
  206. 205.
    Komminoth P (1997) The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications. Virchows Arch 431:1–9PubMedGoogle Scholar
  207. 206.
    Komorowski RA, Hanson GA (1988) Occult thyroid pathology in the young adult: an autopsy study of 138 patients without clinical thyroid disease. Hum Pathol 19:689–696PubMedGoogle Scholar
  208. 207.
    Koperek O, Scheuba C, Puri C, Birner P, Haslinger C, Rettig W, Niederle B, Kaserer K, Garin Chesa P (2007) Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinoma. Int J Oncol 31:59–67PubMedGoogle Scholar
  209. 208.
    Koperek O, Scheuba C, Cherenko M, Neuhold N, De Micco C, Schmid KW, Niederle B, Kaserer K (2008) Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology 52:623–630PubMedGoogle Scholar
  210. 209.
    Koperek O, Prinz A, Scheuba C, Niederle B, Kaserer K (2009) Tenascin C in medullary thyroid microcarcinoma and C-cell hyperplasia. Virchows Arch 455:43–48PubMedGoogle Scholar
  211. 210.
    Koperek O, Asari R, Niederle B, Kaserer K (2011) Desmoplastic stromal reaction in papillary thyroid microcarcinoma. Histopathology 58:919–924PubMedGoogle Scholar
  212. 211.
    Koperek O, Bergner O, Pichlhöfer B, Oberndorfer F, Hainfellner JA, Kaserer K, Horvat R, Harris AL, Niederle B, Birner P (2011) Expression of hypoxia-associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL gene. J Pathol 225:63–72PubMedGoogle Scholar
  213. 212.
    Kovacs GL, Gonda G, Vadasz G, Ludmany E, Uhrin K, Gorombey Z, Kovacs L, Hubina E, Bodo M, Goth MI, Szabolcs I (2005) Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 15:152–157PubMedGoogle Scholar
  214. 213.
    Krause K, Führer D (2008) Molekulare Mechanismen der Schilddrüsentumorgenese. Nuklearmediziner 31:209–215Google Scholar
  215. 214.
    Krisch K, Krisch I, Horvat G, Neuhold N, Ulrich W (1985) The value of immunohistochemistry in medullary thyroid carcinoma: a systematic study of 30 cases. Histopathology 9:1077–1089PubMedGoogle Scholar
  216. 215.
    Krohn K, Führer D, Holzapfel HP, Paschke R (1998) Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. J Clin Endocrinol Metab 83:130–134PubMedGoogle Scholar
  217. 216.
    Krohn K, Paschke R (2002) Somatic mutations in thyroid nodular disease. Mol Genet Metab 75:202–208PubMedGoogle Scholar
  218. 217.
    Krohn K, Führer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R (2005) Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26:504–524PubMedGoogle Scholar
  219. 218.
    Krohn K, Maier J, Paschke R (2007) Mechanisms of disease: Hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors. Nat Clin Pract Endocrinol Metab 3:713–720PubMedGoogle Scholar
  220. 219.
    Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA (2000) PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma. Science 289:1357–1360PubMedGoogle Scholar
  221. 220.
    Kunavisarut T, Kak I, Macmillan C, Ralhan R, Walfish PG (2012) Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma. BMC Cancer 12:523PubMedCentralPubMedGoogle Scholar
  222. 221.
    Kusada N, Hara Y, Kobayashi S, Weihua T, Nakamura Y, Kakudo K, Yuasa H (2005) A case of aggressive carcinoma showing thymus-like differentiation with distant metastases. Thyroid 15:1383–1388PubMedGoogle Scholar
  223. 222.
    Lam KY, Lo CY, Liu MC (2001) Primary squamous cell carcinoma of the thyroid gland: an entity with aggressive clinical behaviour and distinctive cytokeratin expression profiles. Histopathology 39:279–286PubMedGoogle Scholar
  224. 223.
    Lam AK, Lo CY (2006) Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Ann Surg Oncol 13:176–181PubMedGoogle Scholar
  225. 224.
    Landon G, Ordóñez NG (1985) Clear cell variant of medullary carcinoma of the thyroid. Hum Pathol 16:844–847PubMedGoogle Scholar
  226. 225.
    Lang W, Choritz H, Hundeshagen H (1986) Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol 10:246–255PubMedGoogle Scholar
  227. 226.
    Lang W, Borrusch H, Bauer L (1988) Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. Am J Clin Pathol 90:72–76PubMedGoogle Scholar
  228. 227.
    Lazarus JH (1998) The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 8:909–913PubMedGoogle Scholar
  229. 228.
    Lee SL (2010) Complications of radioactive iodine treatment of thyroid carcinoma. J Natl Compr Canc Netw 8:1277–1286PubMedGoogle Scholar
  230. 229.
    Leenhardt L, Grosclaude P (2011) Épidémiologie des cancers thyroïdiens dans le monde. Ann Endocrinol 72:136–148Google Scholar
  231. 230.
    Lecuit M, Caumes E, Bricaire F, Gatineau M, Ménégaux F, Gentilini M (1995) Acute suppurative Salmonella enteritidis thyroiditis associated with thyrotoxicosis in a patient infected with the human immunodeficiency virus. Clin Infect Dis 20:196PubMedGoogle Scholar
  232. 231.
    Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B, Wynford-Thomas D (1989) High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4:159–164PubMedGoogle Scholar
  233. 232.
    Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67PubMedGoogle Scholar
  234. 233.
    Lim DJ, Baek KH, Lee YS, Park WC, Kim MK, Kang MI, Jeon HM, Lee JM, Yun-Cha B, Lee KW, Son HY, Kang SK (2007) Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma. Thyroid 17:883–888PubMedGoogle Scholar
  235. 234.
    Lin JD, Hsueh C, Huang BY (2011) Papillary thyroid carcinoma with different histological patterns. Chang Gung Med J 34:23–34PubMedGoogle Scholar
  236. 235.
    Lin KD, Lin JD, Huang MJ, Huang HS, Jeng LB, Chao TC, Ho YS (1997) Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int Surg 82:378–381PubMedGoogle Scholar
  237. 236.
    Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA (2006) Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107:1255–1264PubMedGoogle Scholar
  238. 237.
    Liu H, Singla A, Ao M, Gill RK, Venkatasubramanian J, Rao MC, Alrefai WA, Dudeja PK (2011) Calcitonin receptor-mediated CFTR activation in human intestinal epithelial cells. J Cell Mol Med 15:2697–2705PubMedCentralPubMedGoogle Scholar
  239. 237a.
    Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar AK, Xing M (2013) Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 20:603–610PubMedCentralPubMedGoogle Scholar
  240. 238.
    LiVolsi VA, Merino MJ (1978) Squamous cells in the human thyroid gland. Am J Surg Pathol 2:133–140PubMedGoogle Scholar
  241. 239.
    LiVolsi VA (1990) Surgical Pathology of the Thyroid. Major Problems in Pathology Bd. 22. W.B. Saunders, PhiladelphiaGoogle Scholar
  242. 240.
    LiVolsi VA (1993) Current concepts in follicular tumors of the thyroid. Monogr Pathol 35:118–137PubMedGoogle Scholar
  243. 241.
    LiVolsi VA (2011) Papillary thyroid carcinoma: an update. Mod Pathol 24(2):1–9Google Scholar
  244. 242.
    LiVolsi VA, Abrosimov AA, Bogdanova T, Fadda G, Hunt JL, Ito M, Rosai J, Thomas GA, Williams ED (2011) The Chernobyl thyroid cancer experience: pathology. Clin Oncol (R Coll Radiol) 23:261–267Google Scholar
  245. 243.
    LiVolsi VA, Baloch ZW (2011) Follicular-patterned tumors of the thyroid: the battle of benign vs. malignant vs. so-called uncertain. Endocr Pathol 22:184–189PubMedGoogle Scholar
  246. 244.
    Ljungberg O, Ericsson UB, Bondeson L, Thorell J (1983) A compound follicular-parafollicular cell carcinoma of the thyroid: a new tumor entity? Cancer 52:1053–1061PubMedGoogle Scholar
  247. 245.
    Ljungberg O (1992) Biopsy pathology of the thyroid and parathyroid. Chapman & Hall, London, S 73–76Google Scholar
  248. 246.
    Lloyd RV, Sisson JC, Marangos PJ (1983) Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma. Cancer 51:2234–2239PubMedGoogle Scholar
  249. 247.
    Lloyd RV (1995) RET proto-oncogene mutations and rearrangements in endocrine diseases. Am J Pathol 147:1539–1544PubMedCentralPubMedGoogle Scholar
  250. 248.
    Lloyd RV, Douglas BR, Young WF (2002) Thyroid Gland. In: Endocrine Diseases. Atlas of Nontumor Pathology AFIP, First Series, Fascicle, Bd. 1., S 91–169Google Scholar
  251. 249.
    Lloyd RV, Buehler D, Khanafshar E (2011) Papillary thyroid carcinoma variants. Head Neck Pathol 5:51–56PubMedCentralPubMedGoogle Scholar
  252. 250.
    Lo CY, Lam KY, Wan KY (1999) Anaplastic carcinoma of the thyroid. Am J Surg 177:337–339PubMedGoogle Scholar
  253. 251.
    Lombardi CP, Bellantone R, De Crea C, Paladino NC, Fadda G, Salvatori M, Raffaelli M (2010) Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area. World J Surg 34:1214–1221PubMedGoogle Scholar
  254. 252.
    Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, Sherman SI (2003) Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 97:1186–1194PubMedGoogle Scholar
  255. 253.
    Lorenz K, Gimm O, Holzhausen HJ, Kittel S, Ukkat J, Thanh PN, Brauckhoff M, Dralle H (2007) Riedel’s thyroiditis: impact and strategy of a challenging surgery. Langenbecks Arch Surg 392:405–412PubMedGoogle Scholar
  256. 254.
    Lueblinghoff J, Eszlinger M, Jaeschke H, Mueller S, Bircan R, Gozu H, Sancak S, Akalin S, Paschke R (2011) Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations. Thyroid 21:221–229PubMedGoogle Scholar
  257. 255.
    Lugli A, Terracciano LM, Oberholzer M, Bubendorf L, Tornillo L (2004) Macrofollicular variant of papillary carcinoma of the thyroid: a histologic, cytologic, and immunohistochemical study of 3 cases and review of the literature. Arch Pathol Lab Med 128:54–58PubMedGoogle Scholar
  258. 256.
    Maceri DR, Babyak J, Ossakow SJ (1986) Lateral neck mass. Sole presenting sign of metastatic thyroid cancer. Arch Otolaryngol Head Neck Surg 112:47–49PubMedGoogle Scholar
  259. 257.
    Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B, Dralle H (2003) European Multiple Endocrine Neoplasia (EUROMEN) Study Group. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517–1525PubMedGoogle Scholar
  260. 258.
    Machens A, Holzhausen HJ, Dralle H (2005) The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 103:2269–2273PubMedGoogle Scholar
  261. 259.
    Machens A, Dralle H (2006) Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside. Mol Cell Endocrinol 247:34–40PubMedGoogle Scholar
  262. 260.
    Magnata Filho LA, Bordallo MA, Pessoa CH, Corbo R, Bulzico DA, Dias FL, Machado AL, Soares AB, Ferman S (2010) Thyroid spindle epithelial tumor with thymus-like differentiation (SETTLE): case report and review. Arq Bras Endocrinol Metabol 54:657–662PubMedGoogle Scholar
  263. 261.
    Magro G, Grasso S (2000) Sustentacular cells in sporadic paraganglioma-like medullary thyroid carcinoma: Report of a case with diagnostic and histogenetic considerations. Pathol Res Pract 196:55–59PubMedGoogle Scholar
  264. 262.
    Manson CM, Cross P, De Sousa B (1992) Post-operative necrotizing granulomas of the thyroid. Histopathology 21:392–393PubMedGoogle Scholar
  265. 263.
    Marcus JN, Dise CA, LiVolsi VA (1982) Melanin production in a medullary thyroid carcinoma. Cancer 49:2518–2526PubMedGoogle Scholar
  266. 264.
    Martin JM, Randhawa G, Temple WJ (1986) Cervical thymoma. Arch Pathol Lab Med 110:354–357PubMedGoogle Scholar
  267. 265.
    Martinez F, Filipowicz E, Hudnall SD (2002) Plasma cell granuloma of the thyroid. Arch Pathol Lab Med 126:595–598PubMedGoogle Scholar
  268. 266.
    Martino E, Bartalena L, Bogazzi F, Braverman LE (2001) The effects of amiodarone on the thyroid. Endocr Rev 22:240–254PubMedGoogle Scholar
  269. 267.
    Martino F, Avila LF, Encinas JL, Luis AL, Olivares P, Lassaletta L, Nistal M, Tovar JA (2006) Teratomas of the neck and mediastinum in children. Pediatr Surg Int 22:627–634PubMedGoogle Scholar
  270. 268.
    Martins T, Carrilho F, Gomes L, Mesquita C, Martins MJ, Carvalheiro M (2006) Malignant teratoma of the thyroid: case report. Thyroid 16:1311–1313PubMedGoogle Scholar
  271. 269.
    Matias-Guiu X, Caixas A, Costa I, Cabezas R, Prat J (1994) Compound medullary-papillary carcinoma of the thyroid: true mixed versus collision tumour [corrected]. Histopathology 25:183–185PubMedGoogle Scholar
  272. 270.
    Matias-Guiu X, Machin P, Pons C, Lagarda E, De Leiva A, Prat J (1998) Sustentacular cells occur frequently in the familial form of medullary thyroid carcinoma. J Pathol 184:420–423PubMedGoogle Scholar
  273. 271.
    Máximo V, Sobrinho-Simões M (2000) Hurthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch 437:107–115PubMedGoogle Scholar
  274. 272.
    Máximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho-Simões M (2005) Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer 92:1892–1898PubMedCentralPubMedGoogle Scholar
  275. 273.
    Máximo V, Soares P, Sobrinho Simoes M (2009) Mitochondria and cancer. Virchows Arch 454:481–495PubMedGoogle Scholar
  276. 274.
    Máximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simões M (2012) The biology and the genetics of Hurthle cell tumors of the thyroid. Endocr Relat Cancer 19:131–147Google Scholar
  277. 275.
    McCluggage WG, Sloan JM (1996) Hyalinizing trabecular carcinoma of thyroid gland. Histopathology 28:357–362PubMedGoogle Scholar
  278. 276.
    McLachlan SM, Prummel MF, Rapoport B (1994) Cell-mediated or humoral immunity in Graves’ ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. J Clin Endocrinol Metab 78:1070–1074PubMedGoogle Scholar
  279. 277.
    McLachlan SM, Rapoport B (2013) Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid 23:14–24PubMedCentralPubMedGoogle Scholar
  280. 278.
    McNicol AM, Lewis (1996) The thyroid gland. In: Lewis (Hrsg) The endocrine system. Systemic pathology, Bd. 12. Churchill Livingstone, New York, S 131–185Google Scholar
  281. 279.
    Mendelsohn G (1984) Signet-cell-simulating microfollicular adenoma of the thyroid. Am J Surg Pathol 8:705–708PubMedGoogle Scholar
  282. 280.
    Menon MP, Khan A (2009) Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications. J Clin Pathol 62:978–985PubMedGoogle Scholar
  283. 281.
    Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, Gardini G, Valcavi R, Barbieri V (2009) Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707–716PubMedGoogle Scholar
  284. 282.
    Mete OASL (2011) Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24:1545–1552PubMedGoogle Scholar
  285. 283.
    Michalek K, Morshed SA, Latif R, Davies TF (2009) TSH receptor autoantibodies. Autoimmun Rev 9:113–116PubMedCentralPubMedGoogle Scholar
  286. 284.
    Mills SEAMS Jr (1986) Congenital occult papillary carcinoma of the thyroid gland. Hum Pathol 17:1179–1181PubMedGoogle Scholar
  287. 285.
    Mizukami Y, Nonomura A, Michigishi T, Noguchi M, Hashimoto T, Nakamura S, Ishizaki T (1994) Solid cell nests of the thyroid. A histologic and immunohistochemical study. Am J Clin Pathol 101:186–191PubMedGoogle Scholar
  288. 286.
    Mizukami Y, Michigishi T, Nonomura A, Nakamura S, Noguchi M, Takazakura E (1995) Histological features of the thyroid gland in a patient with lithium induced thyrotoxicosis. J Clin Pathol 48:582–584PubMedCentralPubMedGoogle Scholar
  289. 287.
    Molberg K, Albores-Saavedra J (1994) Hyalinizing trabecular carcinoma of the thyroid gland. Hum Pathol 25:192–197PubMedGoogle Scholar
  290. 288.
    Motamed M, McGlashan JA (2004) Thyroglossal duct carcinoma. Curr Opin Otolaryngol Head Neck Surg 12:106–109PubMedGoogle Scholar
  291. 289.
    Montone KT, Baloch ZW, LiVolsi VA (2008) The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med 132:1241–1250PubMedGoogle Scholar
  292. 290.
    Moreno A, Rodriguez JM, Sola J, Soria T, Parrilla P (1996) Encapsulated papillary neoplasm of the thyroid: retrospective clinicopathological study with long term follow up. Eur J Surg 162:177–180PubMedGoogle Scholar
  293. 290a.
    Murugan AK, Xing M (2011) Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene. Cancer Res 71:4403-4411PubMedCentralPubMedGoogle Scholar
  294. 291.
    Musholt PB, Musholt TJ, Morgenstern SC, Worm K, Sheu SY, Schmid KW (2008) Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot. World J Surg 32:722–728PubMedGoogle Scholar
  295. 292.
    Musholt TJ, Musholt PB, Khaladj N, Schulz D, Scheumann GF, Klempnauer J (2000) Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma. Surgery 128:984–993PubMedGoogle Scholar
  296. 293.
    Musholt TJ, Musholt PB, Petrich T, Oetting G, Knapp WH, Klempnauer J (2000) Familial papillary thyroid carcinoma: genetics, criteria for diagno-sis, clinical features, and surgical treatment. World J Surg 24:1409–1417PubMedGoogle Scholar
  297. 294.
    Musholt TJ, Brehm C, Hanack J, von Wasielewski R, Musholt PB (2006) Identification of differentially expressed genes in papillary thyroid carcinomas with and without rearrangements of the tyrosine kinase receptors RET and/or NTRK1. J Surg Res 131:15–25PubMedGoogle Scholar
  298. 295.
    Musholt TJ, Clerici T, Dralle H, Frilling A, Goretzki PE, Hermann MM, Kussmann J, Lorenz K, Nies C, Schabram J, Schabram P, Scheuba C, Simon D, Steinmüller T, Trupka AW, Wahl RA, Zielke A, Bockisch A, Karges W, Luster M, Schmid KW, Interdisciplinary Task Force Guidelines of the German Association of Endocrine Surgeons (2011) German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease. Langenbecks Arch Surg 396:639–649PubMedGoogle Scholar
  299. 296.
    Nadig J, Weber E, Hedinger C (1978) C-cell in vestiges of the ultimobranchial body in human thyroid glands. Virchows Arch B Cell Pathol 27:189–191PubMedGoogle Scholar
  300. 297.
    Nakachi K, Hayashi T, Hamatani K, Eguchi H, Kusunoki Y (2008) Sixty years of follow-up of Hiroshima and Nagasaki survivors: current progress in molecular epidemiology studies. Mutat Res 659:109–117PubMedGoogle Scholar
  301. 297a.
    Nakazawa T, Cameselle-Teijeiro J, Vinagre J, Soares P, Rousseau E, Eloy C, Sobrinho-Simões M (2014) C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity. Int J Surg Pathol 22:530–535PubMedGoogle Scholar
  302. 298.
    Nesland JM, Sobrinho-Simões MA, Holm R, Sambade MC, Johannessen JV (1985) Hürthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry. Ultrastruct Pathol 8:269–290PubMedGoogle Scholar
  303. 299.
    Neuhold N, Kaiser H, Kaserer K (2001) Latent carcinoma of the thyroid in Austria: a systematic autopsy study. Endocr Pathol 12:23–31PubMedGoogle Scholar
  304. 300.
    Neuhold N, Schultheis A, Hermann M, Krotla G, Koperek O, Birner P (2011) Incidental papillary microcarcinoma of the thyroid – further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up. Ann Surg Oncol 18:3430–3436PubMedGoogle Scholar
  305. 301.
    Niemeier LA, Kuffner Akatsu H, Song C, Carty SE, Hodak SP, Yip L, Ferris RL, Tseng GC, Seethala RR, Lebeau SO, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforov YE (2012) A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer 118:2069–2077PubMedCentralPubMedGoogle Scholar
  306. 302.
    Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV (2001) Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol 25:1478–1484PubMedGoogle Scholar
  307. 303.
    Nikiforov YE (2002) RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13:3–16PubMedGoogle Scholar
  308. 304.
    Nikiforov YE (2011) Molecular analysis of thyroid tumors. Mod Pathol 2:34–43Google Scholar
  309. 305.
    Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE (2003) BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399–5404PubMedGoogle Scholar
  310. 306.
    Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW 2nd, Tallini G, Kroll TG, Nikiforov YE (2003) RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318–2326PubMedGoogle Scholar
  311. 307.
    Nikiforova MN, Nikiforov YE (2008) Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn 8:83–95PubMedGoogle Scholar
  312. 308.
    Ning S, Song X, Xiang L, Chen Y, Cheng Y, Chen H (2011) Malignant solitary fibrous tumor of the thyroid gland: report of a case and review of the literature. Diagn Cytopathol 39:694–699PubMedGoogle Scholar
  313. 309.
    Nosé V (2011) Familial thyroid cancer: a review. Mod Pathol 24 Suppl 2:19–33Google Scholar
  314. 310.
    O’Neill CJ, Vaughan L, Learoyd DL, Sidhu SB, Delbridge LW, Sywak MS (2011) Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 37:181–185PubMedGoogle Scholar
  315. 311.
    Ottino A, Pianzola HM, Castelletto RH (1989) Occult papillary thyroid carcinoma at autopsy in La Plata, Argentina. Cancer 64:547–551PubMedGoogle Scholar
  316. 312.
    Ozaki O, Ito K, Mimura T, Sugino K, Hosoda Y (1996) Papillary carcinoma of the thyroid. Tall-cell variant with extensive lymphocyte infiltration. Am J Surg Pathol 20:695–698PubMedGoogle Scholar
  317. 313.
    Ozdemir D, Dagdelen S, Erbas T (2010) Endocrine involvement in systemic amyloidosis. Endocr Pract 16:1056–1063PubMedGoogle Scholar
  318. 314.
    Ozkara SK, Gürbüz Y, Müezzinoğlu B, Yumbal Z (2002) Encapsulated cystic papillary variant of medullary carcinoma of thyroid gland. Endocr Pathol 13:167–171PubMedGoogle Scholar
  319. 315.
    Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A (2006) MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13:497–508PubMedGoogle Scholar
  320. 316.
    Pallante P, Visone R, Croce CM, Fusco A (2010) Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer 17:91–104Google Scholar
  321. 317.
    Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimeno C, Barreiro-Morandeira F, Lado-Abeal J (2008) Galician Group for the Study of Toxic Multinodular Goitre, Araujo Vilar D, Argueso R, Barca O, Botana M, Cabezas-Agrícola JM, Catalina P, Dominguez Gerpe L, Fernandez T, Mato A, Nuño A, Penin M, Victoria B. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Eur J Endocrinol 159:623–631PubMedGoogle Scholar
  322. 318.
    Papi G, Corrado S, Cesinaro AM, Novelli L, Smerieri A, Carapezzi C (2002) Riedel’s thyroiditis: clinical, pathological and imaging features. Int J Clin Pract 56:65–67PubMedGoogle Scholar
  323. 319.
    Papi G, LiVolsi V (2004) Current concepts on Riedel Thyreoiditis. Am J Clin Pathol 121:50–S63Google Scholar
  324. 320.
    Papi G, Corrado S, Uberti ED, Roti E (2007) Solitary fibrous tumor of the thyroid gland. Thyroid 17:119–126PubMedGoogle Scholar
  325. 321.
    Papotti M, Negro F, Carney JA, Bussolati G, Lloyd RV (1997) Mixed medullary-follicular carcinoma of the thyroid. A morphological, immunohistochemical and in situ hybridization analysis of 11 cases. Virchows Arch 430:397–405PubMedGoogle Scholar
  326. 322.
    Papotti M, Riella P, Montemurro F, Pietribiasi F, Bussolati G (1997) Immunophenotypic heterogeneity of hyalinizing trabecular tumours of the thyroid. Histopathology 31:525–533PubMedGoogle Scholar
  327. 323.
    Papotti M, Manazza AD, Chiarle R, Bussolati G (2004) Confocal microscope analysis and tridimensional reconstruction of papillary thyroid carcinoma nuclei. Virchows Arch 444:350–355PubMedGoogle Scholar
  328. 324.
    Papotti M, Arrondini M, Tavaglione V, Veltri A, Volante M (2008) Diagnostic controversies in vascular proliferations of the thyroid gland. Endocr Pathol 19:175–183PubMedGoogle Scholar
  329. 325.
    Park CS, Min JS (1989) Lateral neck mass as the initial manifestation of thyroid carcinoma. Head Neck 11:410–413PubMedGoogle Scholar
  330. 326.
    Paschke R, Ludgate M (1997) The thyrotropin receptor in thyroid diseases. N Engl J Med 337:1675–1681PubMedGoogle Scholar
  331. 327.
    Paschke R, Brabant G, Dralle H, Reiners C (2011) Struma diffusa und Knotenstruma. In: Brabant G, Karges W (Kapitelkoordinatoren) Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Thieme, Stuttgart, Sonderauszugsausgabe Schilddrüsenerkrankungen, S 22–28Google Scholar
  332. 328.
    Patten DK, Wani Z, Tolley N (2012) Solitary Langerhans histiocytosis of the thyroid gland: a case report and literature review. Head Neck Pathol 6:279–289PubMedCentralPubMedGoogle Scholar
  333. 329.
    Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A (2004) Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89:3713–3720PubMedGoogle Scholar
  334. 330.
    Pellegriti G, Lumera G, Malandrino P, Latina A, Masucci R, Scollo C, Spadaro A, Sapuppo G, Regalbuto C, Pezzino V, Vigneri R (2013) Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension. J Clin Endocrinol Metab 98:458–465PubMedGoogle Scholar
  335. 331.
    Peretz A, Leiberman E, Kapelushnik J, Hershkovitz E (2004) Thyroglossal duct carcinoma in children: case presentation and review of the literature. Thyroid 14:777–785PubMedGoogle Scholar
  336. 332.
    Perry A, Molberg K, Albores-Saavedra J (1996) Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities. Cancer 77:750–756PubMedGoogle Scholar
  337. 333.
    Piana S, Ragazzi M, Tallini G, de Biase D, Ciarrocchi A, Frasoldati A, Rosai J (2013) Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis. Hum Pathol 44:556–565PubMedGoogle Scholar
  338. 334.
    Pichardo-Lowden A, Durvesh S, Douglas S, Todd W, Bruno M, Goldenberg D (2009) Anaplastic thyroid carcinoma in a young woman: a rare case of survival. Thyroid 19:775–779PubMedGoogle Scholar
  339. 335.
    Piehl S, Hoefig CS, Scanlan TS, Köhrle J (2011) Thyronamines – past, present, and future. Endocr Rev 32:64–80PubMedGoogle Scholar
  340. 336.
    Pilarsky R (2009) Cowden Syndrome: a critical review of the clinical literature. J Gent Counsel 18:13–27Google Scholar
  341. 337.
    Pilotti S, Collini P, Mariani L, Placucci M, Bongarzone I, Vigneri P, Cipriani S, Falcetta F, Miceli R, Pierotti MA, Rilke F (1997) Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland. Am J Surg Pathol 21:1466–1473PubMedGoogle Scholar
  342. 338.
    Ponder BAJ (2002) Multiple endocrine neoplasia type 2. In: Vogelstein B, Kinzler KW (Hrsg) The genetic basis of human cancer, 2. Aufl. McGraw-Hill, New York, S 501–513Google Scholar
  343. 339.
    Pritchyk K, Newkirk K, Garlich P, Deeb Z (2004) Tamoxifen therapy for Riedel’s thyroiditis. Laryngoscope 114:1758–1760PubMedGoogle Scholar
  344. 340.
    Quadbeck B, Eckstein AK, Tews S, Walz M, Hoermann R, Mann K, Gieseler R (2002) Maturation of thyroidal dendritic cells in Graves’ disease. Scand J Immunol 55:612–620PubMedGoogle Scholar
  345. 341.
    Rambaud JC, Jian R, Flourié B, Hautefeuille M, Salmeron M, Thuillier F, Ruskoné A, Florent C, Chaoui F, Bernier JJ (1988) Pathophysiological study of diarrhoea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit time. Gut 29:537–543PubMedCentralPubMedGoogle Scholar
  346. 342.
    Ramp U, Pfitzer P, Gabbert HE (1995) Fine needle aspiration (FNA)-induced necrosis of tumours of the thyroid. Cytopathology 6:248–254PubMedGoogle Scholar
  347. 343.
    Raue F, Frank-Raue K (2009) Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management. Hormones (Athens) 8:23–28Google Scholar
  348. 344.
    Regensburg NI, Wiersinga WM, Berendschot TT, Potgieser P, Mourits MP (2011) Do subtypes of Graves’ orbitopathy exist? Ophthalmol 118:191–196Google Scholar
  349. 345.
    Reid JD, Choi CH, Oldroyd NO (1987) Calcium oxalate crystals in the thyroid. Their identification, prevalence, origin, and possible significance. Am J Clin Pathol 87:443–454PubMedGoogle Scholar
  350. 346.
    Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, Schumm-Draeger PM (2004) Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 14:926–932PubMedGoogle Scholar
  351. 347.
    Reiners C, Paschke R, Mann K (2011) Funktionelle Autonomie. In: Brabant G, Karges W (Kapitelkoordinatoren) Rationelle Diagnostik und Therapie in Endokrinologie, Diabetologie und Stoffwechsel. Thieme, Stuttgart, Sonderauszugsausgabe Schilddrüsenerkrankungen, S 28–30Google Scholar
  352. 348.
    Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simões (2003) p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol 16:43–48PubMedGoogle Scholar
  353. 348a.
    Ricarte-Filho JC, Ryder M, Chitale DA, Rivera M, Heguy A, Ladanyi M, Janakiraman M, Solit D, Knauf JA, Tuttle RM, Ghossein RA, Fagin JA (2009) Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res 69:4885–4893PubMedCentralPubMedGoogle Scholar
  354. 349.
    Riedlinger WF, Lack EE, Robson CD, Rahbar R, Nose V (2005) Primary thyroid teratomas in children: a report of 11 cases with a propsal of criteria for their diagnosis. Am J Surg Pathol 29:700–706PubMedGoogle Scholar
  355. 350.
    Rigaud C, Peltier F, Bogomoletz WV (1985) Mucin producing microfollicular adenoma of the thyroid. J Clin Pathol 38:277–280PubMedCentralPubMedGoogle Scholar
  356. 351.
    Rivera M, Tuttle RM, Patel S, Shaha A, Shah JP, Ghossein RA (2009) Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid 19:119–127PubMedGoogle Scholar
  357. 352.
    Rivera M, Ricarte-Filho J, Patel S, Tuttle M, Shaha A, Shah JP, Fagin JA, Ghossein RA (2010) Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol 41:172–180PubMedGoogle Scholar
  358. 353.
    Rocha AS, Soares P, Machado JC, Máximo V, Fonseca E, Franssila K, Sobrinho-Simões M (2002) Mucoepidermiod carcinoma of the thyroid: a tumour histotype characterized by P-caherin neoexpression and marked abnormalities of the E-cadherin/catenins complex. Virchows Arch 440:498–504PubMedGoogle Scholar
  359. 354.
    Rodriguez I, Ayala E, Caballero C, De Miguel C, Matias-Guiu X, Cubilla AL, Rosai J (2001) Solitary fibrous tumor of the thyroid gland: report of seven cases. Am J Surg Pathol 25:1424–1428PubMedGoogle Scholar
  360. 355.
    Roka S, Kornek G, Schüller J, Ortmann E, Feichtinger J, Armbruster C (2004) Carcinoma showing thymic-like elements – a rare malignancy of the thyroid gland. Br J Surg 91:142–145PubMedGoogle Scholar
  361. 356.
    Rosai J, Saxén EA, Woolner L (1985) Undifferentiated and poorly differentiated carcinoma. Semin Diagn Pathol 2:123–136PubMedGoogle Scholar
  362. 357.
    Rosai J, Carcangiu ML, DeLellis RA (1992) Tumors of the Thyroid Gland. Atlas of Tumor Pathology AFIP, Third Series, Bd. 5. Armed Forces Institute of Pathology, Washington, D.CGoogle Scholar
  363. 358.
    Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED (2003) Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol 11:249–251PubMedGoogle Scholar
  364. 359.
    Rosai J (2005) Handling of thyroid follicular patterned lesions. Endocr Pathol 16:279–283PubMedGoogle Scholar
  365. 360.
    Rothenberg HJ, Goellner JR, Carney JA (1999) Hyalinizing trabecular adenoma of the thyroid gland: recognition and characterization of its cytoplasmic yellow body. Am J Surg Pathol 23:118–125PubMedGoogle Scholar
  366. 361.
    Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE, Degli Uberti EC (2006) Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 91:2171–2178PubMedGoogle Scholar
  367. 362.
    Roti E, degli Uberti EC, Bondanelli M, Braverman LE (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159:659–673PubMedGoogle Scholar
  368. 363.
    Rufini V, Salvatori M, Fadda G, Pinnarelli L, Castaldi P, Maussier ML, Galli G (2007) Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns. Cancer 110:1209–1217PubMedGoogle Scholar
  369. 364.
    Russo D, Arturi F, Schlumberger M, Caillou B, Monier R, Filetti S, Suárez HG (1995) Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene 11:1907–1911PubMedGoogle Scholar
  370. 365.
    Ryska A, Vokurka J, Michal M, Ludvíková M (1997) Intrathyroidal lymphoepithelial cyst. A report of two cases not associated with Hashimoto’s thyroiditis. Pathol Res Pract 193:777–781PubMedGoogle Scholar
  371. 366.
    Ryska A, Ludvíková M, Rydlová M, Cáp J, Zalud R (2006) Massive squamous metaplasia of the thyroid gland - report of three cases. Pathol Res Pract 202:99–106PubMedGoogle Scholar
  372. 367.
    Sadow PM, Hunt JL (2010) Mixed Medullary-follicular-derived carcinomas of the thyroid gland. Adv Anat Pathol 17:282–285PubMedGoogle Scholar
  373. 368.
    Saggiorato E, Rapa I, Garino F, Bussolati G, Orlandi F, Papotti M, Volante M (2007) Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia. J Mol Diagn 9:214–219PubMedCentralPubMedGoogle Scholar
  374. 369.
    Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849–1855PubMedGoogle Scholar
  375. 370.
    Salajegheh A, Petcu EB, Smith RA, Lam AK (2008) Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists. Postgrad Med J 84:78–82PubMedGoogle Scholar
  376. 371.
    Salvatore G, Chiappetta G, Nikiforov YE et al (2005) Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations. Eur J Cancer 41:816–821PubMedGoogle Scholar
  377. 372.
    Sambade C, Baldaque-Faria A, Cardoso-Oliveira M, Sobrinho-Simões M (1988) Follicular and papillary variants of medullary carcinoma of the thyroid. Pathol Res Pract 184:98–107PubMedGoogle Scholar
  378. 373.
    Sampson RJ, Key CR, Buncher CR, Iijima S (1971) Smallest forms of papillary carcinoma of the thyroid. A study of 141 microcarcinomas less than 0.1 cm in greatest dimension. Arch Pathol 91:334–339PubMedGoogle Scholar
  379. 374.
    Sampson RJ, Woolner LB, Bahn RC, Kurland LT (1974) Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer 34:2072–2076PubMedGoogle Scholar
  380. 375.
    Santeusanio G, Schiaroli S, Ortenzi A, Mulè A, Perrone G, Fadda G (2008) Solitary fibrous tumour of thyroid: report of two cases with immunohistochemical features and literature review. Head Neck Pathol 2:231–235PubMedCentralPubMedGoogle Scholar
  381. 376.
    Sargent R, LiVolsi V, Murphy J, Mantha G, Hunt JL (2006) BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis. Endocr Pathol 17:235–241PubMedGoogle Scholar
  382. 377.
    Satge D, Grob JC, Pusel J, Methlin G (1990) [Thyroid microcarcinoma with a fatal outcome and 34 other unusually aggressive cases reported in the literature]. Arch Anat Cytol Pathol 38:143–151PubMedGoogle Scholar
  383. 378.
    Scheuba C, Kaserer K, Weinhäusl A, Pandev R, Kaider A, Passler C, Prager G, Vierhapper H, Haas OA, Niederle B (1999) Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery 126:1089–1095PubMedGoogle Scholar
  384. 379.
    Scheuba C, Kaserer K, Kotzmann H, Bieglmayer C, Niederle B, Vierhapper H (2000) Prevalence of C-cell hyperplasia in patients with normal basal and pentagastrin-stimulated calcitonin. Thyroid 10:413–416PubMedGoogle Scholar
  385. 380.
    Scheuba C, Kaserer K, Kaczirek K, Asari R, Niederle B (2006) Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative ″marker″ for lymph node metastases. World J Surg 30:853–859PubMedGoogle Scholar
  386. 381.
    Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338:297–306PubMedGoogle Scholar
  387. 382.
    Schmid KW, Hofstädter F (1984) Thymic inclusion in the thyroid gland of a premature birth of the 36th week of gestation. Acta Anat 120:65Google Scholar
  388. 383.
    Schmid KW, Fischer-Colbrie R, Hagn C, Jasani B, Williams ED, Winkler H (1987) Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid. Am J Surg Pathol 11:551–556PubMedGoogle Scholar
  389. 384.
    Schmid KW, Tötsch M, Hittmair A, Feichtinger H, Ladurner D, Hofstädter F (1989) Frequency of medullary thyroid carcinoma in an endemic goiter area. Mod Pathol 2:90–93PubMedGoogle Scholar
  390. 385.
    Schmid KW, Hittmair A, Ofner C, Tötsch M, Ladurner D (1991) Metastatic tumors in fine needle aspiration biopsy of the thyroid. Acta Cytol 35:722–724PubMedGoogle Scholar
  391. 386.
    Schmid KW, Kirchmair R, Ladurner D, Fischer-Colbrie R, Böcker W (1992) Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid. Histopathology 21:225–232PubMedGoogle Scholar
  392. 387.
    Schmid KW (1993) Subacute granulomatous (deQuervain´s) thyroiditis. Am Soc Clin Pathol, Check Sample Continuing Education Program AP 93-7: 1–4Google Scholar
  393. 388.
    Schmid KW, Böcker W (1993) Medulläres Schilddrüsenkarzinom. Immunhistochemische Marker in Histopathololgie und Forschung. Zentralbl Pathol 139:115–129PubMedGoogle Scholar
  394. 389.
    Schmid KW, Morgan JM, Baumert M, Fischer-Colbrie R, Böcker W, Jasani B (1995) Calcitonin and calcitonin gene-related peptide mRNA detection in a population of hyperplastic parathyroid cells also expressing chromogranin B. Lab Invest 73:90–95PubMedGoogle Scholar
  395. 390.
    Schmid KW, Tötsch M, Öfner D, Böcker W, Ladurner D (1997) Minimally invasive follicular thyroid carcinoma: a clinico-pathological study. Curr Top Pathol 91:37–43PubMedGoogle Scholar
  396. 391.
    Schmid KW, Ensinger C (1998) Atypical″ medullary thyroid carcinoma with little or no calcitonin expression. Virchows Arch 433:209–215PubMedGoogle Scholar
  397. 392.
    Schmid KW, Sheu SY, Görges R, Ensinger C, Tötsch M (2003) Tumoren der Schilddrüse. Pathologe 24:357–372PubMedGoogle Scholar
  398. 393.
    Schmid KWWC (2003) Die missglückte Klassifikation. Pathologe 24:338Google Scholar
  399. 394.
    Schmid KW, Farid NR (2006) How to define follicular thyroid carcinoma? Virchows Arch 448:385–393PubMedGoogle Scholar
  400. 395.
    Schmid KW (2010) Pathogenese, Klassifikation und Histologie von Schilddrüsenkarzinomen. Onkologe 16:644–656Google Scholar
  401. 396.
    Schmid KW, Ting S, Sheu SY (2010) Familiäre Karzinome der Schilddrüse. Pathologe 31:485–488PubMedGoogle Scholar
  402. 397.
    Schmitz KJ, Baumgaertel MW, Schmidt C, Sheu SY, Betzler M, Schmid KW (2008) Wegener’s granulomatosis in the thyroid mimicking a tumour. Virchows Arch 452:571–574PubMedGoogle Scholar
  403. 398.
    Schröder S, Böcker W, Dralle H, Kortmann KB, Stern C (1984) The encapsulated papillary carcinoma of the thyroid. A morphologic subtype of the papillary thyroid carcinoma. Cancer 54:90–93PubMedGoogle Scholar
  404. 399.
    Schröder S, Böcker W, Hüsselmann H, Dralle H (1984) Adenolipoma (thyrolipoma) of the thyroid gland report of two cases and review of literature. Virchows Arch A Pathol Anat Histopathol 404:99–103PubMedGoogle Scholar
  405. 400.
    Schröder S, Hüsselmann H, Böcker W (1984) Lipid-rich cell adenoma of the thyroid gland. Report of a peculiar thyroid tumour. Virchows Arch A Pathol Anat Histopathol 404:105–108PubMedGoogle Scholar
  406. 401.
    Schröder S, Klöppel G (1987) Carcinoembryonic antigen and nonspecific cross-reacting antigen in thyroid cancer. An immunocytochemical study using polyclonal and monoclonal antibodies. Am J Surg Pathol 11:100–108PubMedGoogle Scholar
  407. 402.
    Schröder S, Böcker W, Baisch H, Bürk CG, Arps H, Meiners I, Kastendieck H, Heitz PU, Klöppel G (1988) Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer 61:806–816PubMedGoogle Scholar
  408. 403.
    Schwertheim S, Sheu SY, Worm K, Grabellus F, Schmid KW (2009) Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma. Hormone and Metabolic Research 41:475–481PubMedGoogle Scholar
  409. 404.
    Serra SASL (2008) Controversies in thyroid pathology: the diagnosis of follicular neoplasms. Endocr Pathol 19:156–165PubMedGoogle Scholar
  410. 405.
    Shahi N, Abdelhamid MF, Jindall M, Awad RW (2010) Riedel’s thyroiditis masquerading as anaplastic thyroid carcinoma: a case report. J Med Case Rep 4:15PubMedCentralPubMedGoogle Scholar
  411. 406.
    Sheu SY, Schmid KW (2003) Entzündliche Schilddrüsenerkrankungen. Epidemiologie, Klinik und Morphologie. Pathologe 24:339–347PubMedGoogle Scholar
  412. 407.
    Sheu SY, Görges R, Schmid KW (2003) Hyperplasien der Schilddrüse. Pathologe 24:348–356PubMedGoogle Scholar
  413. 408.
    Sheu SY, Wenzel RR, Kersting C, Merten R, Otterbach F, Schmid KW (2004) Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literature. J Clin Pathol 57:1225–1228PubMedCentralPubMedGoogle Scholar
  414. 409.
    Sheu SY, Frilling A, Betzler M, Peitsch W, Schmid KW (2005) Der intraoperative Gefrierschnitt von Schilddrüsenknoten. lndikation - Verlässlichkeit - Grenzen. Viszeralchirurgie 40:174–179Google Scholar
  415. 410.
    Sheu SY, Levin S, Schmid KW (2006) Therapiebedingte Veränderungen der Schilddrüse. Pathologe 27:13–18PubMedGoogle Scholar
  416. 411.
    Sheu SY, Schwertheim S, Worm K, Grabellus F, Schmid KW (2007) Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. Mod Pathol 20:779–787PubMedGoogle Scholar
  417. 412.
    Sheu SY, Grabellus F, Schwertheim S, Handke S, Worm K, Schmid KW (2009) Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma. Horm Metab Res 41:482–487PubMedGoogle Scholar
  418. 413.
    Sheu SY, Vogel E, Worm K, Grabellus F, Schwertheim S, Schmid KW (2010) Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma. Histopathology 56:632–640PubMedGoogle Scholar
  419. 414.
    Sheu SY, Grabellus F, Schwertheim S, Worm K, Broecker-Preuss M, Schmid KW (2010) Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer 102:376–382PubMedCentralPubMedGoogle Scholar
  420. 415.
    Sheu SY, Schmid KW (2010) Multiple endocrine Neoplasien Typ 2. Pathologe 31:449–454 (Erratum Pathologe (2011) 32: 82)PubMedGoogle Scholar
  421. 416.
    Shimizu M, Hirokawa M, Manabe T (1999) Parasitic nodule of the thyroid in a patient with Graves’ disease. Virchows Arch 434:241–244PubMedGoogle Scholar
  422. 417.
    Singh K, Sharma MC, Jain D, Kumar R (2008) Melanotic medullary carcinoma of thyroid--report of a rare case with brief review of literature. Diagn Pathol 3:2PubMedCentralPubMedGoogle Scholar
  423. 418.
    Sippel RS, Caron NR, Clark OH (2007) An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31:924–933PubMedGoogle Scholar
  424. 419.
    Skacel M, Ross CW, Hsi ED (2000) A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma. Histopathology 37:10–18PubMedGoogle Scholar
  425. 420.
    Sneed DC (1999) Protocol for the examination of specimens from patients with malignant tumors of the thyroid gland, exclusive of lymphomas. Arch Pathol Lab Med 123:45–49PubMedGoogle Scholar
  426. 421.
    Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Máximo V, Botelho T, Seruca R, Sobrinho-Simões M (2003) BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578–4580PubMedGoogle Scholar
  427. 422.
    Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M (2011) Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Curr Genomics 12:609–617PubMedCentralPubMedGoogle Scholar
  428. 423.
    Sobin LH, Gospodarowicz M, Wittekind C (2009) TNM Classification of Malignant Tumours, 7. Aufl. Wiley-Liss, New York, S 58–62Google Scholar
  429. 424.
    Sobrinho-Simoes MA, Sambade MC, Goncalves V (1979) Latent thyroid carcinoma at autopsy. Cancer 43:1702–1706PubMedGoogle Scholar
  430. 425.
    Sobrinho-Simões M, Preto A, Rocha AS, Castro P, Máximo V, Fonseca E, Soares P (2005) Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch 447:787–793PubMedGoogle Scholar
  431. 426.
    Sobrinho-Simões M, Máximo V, Rocha AS, Trovisco V, Castro P, Preto A, Lima J, Soares P (2008) Intragenic mutations in thyroid cancer. Endocrinol Metab Clin North Am 37:333–362PubMedGoogle Scholar
  432. 427.
    Sobrinho-Simões M, Eloy C, Magalhães J, Lobo C, Amaro T (2011) Follicular thyroid carcinoma. Mod Pathol 2:10–18Google Scholar
  433. 428.
    Song Z, Yu C, Song X, Wei L, Liu A (2011) Primary solitary fibrous tumor of the thyroid - report of a case and review of the literature. J Cancer 2:206–209PubMedCentralPubMedGoogle Scholar
  434. 429.
    Spires JR, Schwartz MR, Miller RH (1988) Anaplastic thyroid carcinoma. Association with differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 114:40–44PubMedGoogle Scholar
  435. 430.
    Stein SA, Wartofsky L (2013) Primary Thyroid Lymphoma: A Clinical Review. J Clin Endocrinol Metab 98:3131–3138PubMedGoogle Scholar
  436. 431.
    Stocker DJ, Burch HB (2003) Thyroid cancer yield in patients with Graves’ disease. Minerva Endocrinol 28:205–212PubMedGoogle Scholar
  437. 432.
    Stratakis CA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA, Shawker T (1997) Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab 82:2037–2043PubMedGoogle Scholar
  438. 433.
    Sugino K, Ito K Jr, Ozaki O, Mimura T, Iwasaki H, Ito K (1998) Papillary microcarcinoma of the thyroid. J Endocrinol Invest 21:445–448PubMedGoogle Scholar
  439. 434.
    Sugitani I, Yanagisawa A, Shimizu A, Kato M, Fujimoto Y (1998) Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg 22:731–737PubMedGoogle Scholar
  440. 435.
    Syed MI, Stewart M, Syed S, Dahill S, Adams C, McLellan DR, Clark LJ (2011) Squamous cell carcinoma of the thyroid gland: primary or secondary disease? J Laryngol Otol 125:3–9PubMedGoogle Scholar
  441. 436.
    Takeda M, Mikami T, Numata Y, Okamoto M, Okayasu I (2013) Papillary thyroid carcinoma with heterotopic ossification is a special subtype with extensive progression. Am J Clin Pathol 139:587–598PubMedGoogle Scholar
  442. 437.
    Tallini G, Santoro M, Helie M, Carlomagno F, Salvatore G, Chiappetta G, Carcangiu ML, Fusco A (1998) RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res 4:287–294PubMedGoogle Scholar
  443. 438.
    Tanboon J, Keskool P (2013) Leiomyosarcoma: A rare tumor of the thyroid. Endocr Pathol 24:126–143Google Scholar
  444. 439.
    Taweevisit M, Sampatanukul P, Thorner PS (2013) Ectopic thymoma can mimic benign and malignant thyroid lesions on fine needle aspiration cytology: a case report and literature review. Acta Cytol 57:213–220PubMedGoogle Scholar
  445. 440.
    Tetzlaff MT, Liu A, Xu X, Master SR, Baldwin DA, Tobias JW, Livolsi VA, Baloch ZW (2007) Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocrine Pathology 18:163–173PubMedGoogle Scholar
  446. 441.
    Ting S, Puttinger C, Schmid KW, Sheu-Grabellus SY (2012) Der hyalinisierende trabekuläre Tumor der Schilddrüse. Eine übertrieben vorsichtige Bezeichnung für einen gutartigen Tumor? Pathologe 33:135–141PubMedGoogle Scholar
  447. 442.
    Thompson LD, Wenig BM, Adair CF, Heffess CS (1996) Peripheral Nerve Sheath Tumors of the Thyroid Gland: A Series of Four Cases and a Review of the Literature. Endocr Pathol 7:309–318PubMedGoogle Scholar
  448. 443.
    Thompson LD, Wenig BM, Adair CF, Shmookler BM, Heffess CS (1997) Primary smooth muscle tumors of the thyroid gland. Cancer 79:579–587PubMedGoogle Scholar
  449. 444.
    Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS (2001) A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 91:505–524PubMedGoogle Scholar
  450. 445.
    Torres-Montaner A, Beltrán M, de la Romero Osa A, Oliva H (2001) Sarcoma of the thyroid region mimicking Riedel’s thyroiditis. J Clin Pathol 54:570–572PubMedCentralPubMedGoogle Scholar
  451. 446.
    Tóth K, Péter I, Kremmer T, Sugár J (1990) Lipid-rich cell thyroid adenoma: histopathology with comparative lipid analysis. Virchows Arch A Pathol Anat Histopathol 417:273–276PubMedGoogle Scholar
  452. 447.
    Trovisco V, de Vieira Castro I, Soares P, Máximo V, Silva P, Magalhães J, Abrosimov A, Guiu XM, Sobrinho-Simões M (2004) BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 202:247–251PubMedGoogle Scholar
  453. 448.
    Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, Caillou B, Travagli JP, Parmentier C (1985) Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794–804PubMedGoogle Scholar
  454. 449.
    Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493Google Scholar
  455. 450.
    Ueki I, Ando T, Haraguchi A, Horie I, Imaizumi M, Hayashi T, Uga T, Usa T, Kawakami A (2011) A case of mixed medullary and follicular cell carcinoma of the thyroid. Intern Med 50:1313–1316PubMedGoogle Scholar
  456. 451.
    Uribe M, Fenoglio-Preiser CM, Grimes M, Feind C (1985) Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature. Am J Surg Pathol 9:577–594PubMedGoogle Scholar
  457. 452.
    van Heerden JA, Hay ID, Goellner JR, Salomao D, Ebersold JR, Bergstralh EJ, Grant CS (1992) Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 112:1130–1136PubMedGoogle Scholar
  458. 453.
    Vantyghem MC, Pigny P, Leteurtre E, Leclerc L, Bauters C, Douillard C, D’Herbomez M, Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M (2204) Thyroid carcinomas involving follicular and parafollicular C cells: seventeen cases with characterization of RET oncogenic activation. Thyroid 14:842–847Google Scholar
  459. 454.
    Vaidya B, Harris PE, Barrett P, Kendall-Taylor P (1997) Corticosteroid therapy in Riedel’s thyroiditis. Postgrad Med J 73:817–819PubMedCentralPubMedGoogle Scholar
  460. 455.
    Vailati A, Marena C, Aristia L, Sozzé E, Barosi G, Inglese V, Luisetti M, Bossolo PA (1993) Sarcoidosis of the thyroid: report of a case and a review of the literature. Sarcoidosis 10:66–68PubMedGoogle Scholar
  461. 456.
    Vargas PA, Bernardi FD, Alves VA, Gianotti MA, Almeida OP, Saldiva PH, Mauad T (2000) Uncommon histopathological findings in fatal measles infection: pancreatitis, sialoadenitis and thyroiditis. Histopathology 37:141–146PubMedGoogle Scholar
  462. 457.
    Vasko VV, Gaudart J, Allasia C, Savchenko V, Di Cristofaro J, Saji M, Ringel MD, De Micco C (2004) Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma. Eur J Endocrinol 151:779–786PubMedGoogle Scholar
  463. 458.
    Veits L, Mechtersheimer G, Steger C, Freitag J, Mikuz G, Schmid KW, Hofmann W, Schirmacher P, Hartmann A, Rieker RJ (2011) Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE). Virchows Arch 459:221–226PubMedGoogle Scholar
  464. 459.
    Vergilio J, Baloch ZW, LiVolsi VA (2002) Spindle cell metaplasia of the thyroid arising in association with papillary carcinoma and follicular adenoma. Am J Clin Pathol 117:199–204PubMedGoogle Scholar
  465. 460.
    Verkooijen HM, Fioretta G, Pache JC, Franceschi S, Raymond L, Schubert H, Bouchardy C (2003) Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14:13–17PubMedGoogle Scholar
  466. 461.
    Vickery AL Jr, Carcangiu ML, Johannessen JV, Sobrinho-Simoes M (1985) Papillary carcinoma. Semin Diagn Pathol 2:90–100PubMedGoogle Scholar
  467. 462.
    Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhäusl A, Niederle B (1997) Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589–1593PubMedGoogle Scholar
  468. 463.
    Villa F, Dionigi G, Tanda ML, Rovera F, Boni L (2008) Amyloid goiter. Int J Surg 6 Suppl 1:16–18Google Scholar
  469. 464.
    Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco A (2007) Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26:7590–7595PubMedGoogle Scholar
  470. 465.
    Volante M, Papotti M, Roth J, Saremaslani P, Speel EJ, Lloyd RV, Carney JA, Heitz PU, Bussolati G, Komminoth P (1999) Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components. Am J Pathol 155:1499–1509PubMedCentralPubMedGoogle Scholar
  471. 466.
    Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–1264PubMedGoogle Scholar
  472. 467.
    Volante M, Rapa I, Gandhi M, Bussolati G, Giachino D, Papotti M, Nikiforov YE (2009) RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab 94:4735–4741PubMedGoogle Scholar
  473. 468.
    Vriens MR, Schreinemakers JM, Suh I, Guerrero MA, Clark OH (2009) Diagnostic markers and prognostic factors in thyroid cancer. Future Oncol 5:1283–1293PubMedGoogle Scholar
  474. 469.
    Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283:1482–1488PubMedGoogle Scholar
  475. 470.
    Wan SK, Chan JK, Tang SK (1996) Paucicellular variant of anaplastic thyroid carcinoma. A mimic of Reidel’s thyroiditis. Am J Clin Pathol 105:388–393PubMedGoogle Scholar
  476. 471.
    Wang K, Klionsky DJ (2011) Mitochondria removal by autophagy. Autophagy 7:297–300PubMedCentralPubMedGoogle Scholar
  477. 472.
    Wang SA, Rahemtullah A, Faquin WC, Roepke J, Harris NL, Hasserjian RP (2005) Hodgkin’s lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature. Mod Pathol 18:1577–1584PubMedGoogle Scholar
  478. 473.
    Wartofsky L (2012) Management of papillary microcarcinoma: primum non nocere? J Clin Endocrinol Metab 97:1169–1172 (Erratum in: J Clin Endocrinol Metab 97: 1786)PubMedGoogle Scholar
  479. 474.
    Weber A, Schmid KW, Tannapfel A, Wittekind C (2010) Neuerungen der TNM-Klassifikation der Kopf-Hals-Tumoren. Pathologe 31:339–343PubMedGoogle Scholar
  480. 475.
    Weetman AP (2001) Determinants of autoimmune thyroid disease. Nat Immunol 2:769–770PubMedGoogle Scholar
  481. 476.
    Weinhaeusel A, Scheuba C, Lauss M, Kriegner A, Kaserer K, Vierlinger K, Haas OA, Niederle B (2008) The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma. Thyroid 18:1269–1276PubMedGoogle Scholar
  482. 477.
    Wenig BM, Heffess CS, Adair CF (1997) Thyroid paraganglioma. In: Atlas of Endocrine Pathology. W.B. Saunders, Philadelphia, S 144Google Scholar
  483. 478.
    Williams D (2008) Radiation carcinogenesis: lessons from Chernobyl. Oncogene 2:9–18Google Scholar
  484. 479.
    Williams ED, Toyn CE, Harach HR (1989) The ultimobranchial gland and congenital thyroid abnormalities in man. J Pathol 159:135–141PubMedGoogle Scholar
  485. 480.
    Williams ED (2000) Guest Editorial: Two Proposals Regarding the Terminology of Thyroid Tumors. Int J Surg Pathol 8:181–183PubMedGoogle Scholar
  486. 481.
    Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH (2003) TNM Supplement. A commentary on uniform use, 3. Aufl. Wiley-Liss, New York, S 138Google Scholar
  487. 482.
    Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F, Neumann HP (2010) Multiple endocrine neoplasia type 2. Best Pract Res Clin Endocrinol Metab 24:371–387PubMedGoogle Scholar
  488. 483.
    Wohlschlaeger J, Ebert S, Sheu SY, Schmid KW, Totsch M (2009) Immunocytochemical investigation of Langerin (CD207) is a valuable adjunct in the cytological diagnosis of Langerhans cell histiocytosis of the thyroid. Pathol Res Pract 205:433–436PubMedGoogle Scholar
  489. 484.
    Wolfe HJ, DeLellis RA, Voelkel EF, Tashjian AH Jr (1975) Distribution of calcitonin-containing cells in the normal neonatal human thyroid gland: a correlation of morphology with peptide content. J Clin Endocrinol Metab 41:1076–1081PubMedGoogle Scholar
  490. 485.
    Woo Young K, Young Ran K, Sang Uk W, Jae Bok L (2011) Pulmonary leiomyosarcoma metastatic to the thyroid gland: case report and review of the literature. Ann Endocrinol 72:314–316Google Scholar
  491. 486.
    Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B (2004) Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer 40:355–364PubMedGoogle Scholar
  492. 486a.
    Wu G, Mambo E, Guo Z, Hu S, Huang X, Gollin SM, Trink B, Ladenson PW, Sidransky D, Xing M (2005) Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors. JCEM 90:4688–4693PubMedGoogle Scholar
  493. 487.
    Wynford-Thomas D (1994) Thyroid cancer. In: Lemoine N, Neoptolemos J, Cooke T (Hrsg) Cancer. A molecular approach. Blackwell Scientific Publications, London, S 192–222Google Scholar
  494. 488.
    Xia CX, Li R, Wang ZH, Lv FJ, Tang XQ, Li QF, Zhang SH (2012) A rare cause of goiter: Langerhans cell histiocytosis of the thyroid. Endocr J 59:47–54PubMedGoogle Scholar
  495. 489.
    Xing M (2005) BRAF mutation in thyroid cancer. Endocr Relat Cancer 12:245–26PubMedGoogle Scholar
  496. 490.
    Xing M (2008) Recent advances in molecular biology of thyroid cancer and their clinical implications. Otolaryngol Clin North Am 41:1135–1146PubMedCentralPubMedGoogle Scholar
  497. 490a.
    Xing M (2010) Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer. Thyroid 20:697–706PubMedCentralPubMedGoogle Scholar
  498. 490b.
    Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, Pai S, Bishop J (2014) BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol 32:2718–2726PubMedGoogle Scholar
  499. 491.
    Xu B, Hirokawa M, Yoshimoto K, Miki H, Takahashi M, Kuma S, Sano T (2003) Spindle epithelial tumor with thymus-like differentiation of the thyroid: a case report with pathological and molecular genetics study. Hum Pathol 34:190–193PubMedGoogle Scholar
  500. 492.
    Yagawa K, Takahashi S, Murata T (1966) Clinico-pathological study of latent thyroid carcinoma. Proceedings of the Japanese Cancer Association, 25th Annual Meeting 106 (abstract)Google Scholar
  501. 493.
    Yamamoto Y, Maeda T, Izumi K, Otsuka H (1990) Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer 65:1173–1179PubMedGoogle Scholar
  502. 494.
    Yu XM, Wan Y, Sippel RS, Chen H (2011) Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg 254:653–660PubMedGoogle Scholar
  503. 495.
    Zantour B, Guilhaume B, Tissier F, Louvel A, Jeunemaitre X, Gimenez-Roqueplo AP, Bertagna X (2004) A thyroid nodule revealing a paraganglioma in a patient with a new germline mutation in the succinate dehydrogenase B gene. Eur J Endocrinol 151:433–438PubMedGoogle Scholar
  504. 496.
    Zheng X, Wei S, Han Y, Li Y, Yu Y, Yun X, Ren X, Gao M (2013) Papillary Microcarcinoma of the Thyroid: Clinical Characteristics and BRAF(V600E) Mutational Status of 977 Cases. Ann Surg Oncol 20:2266–2273PubMedGoogle Scholar
  505. 497.
    Zhu Z, Gandhi M, Nikiforova MN, Fischer AH, Nikiforov YE (2003) Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 120:71–77PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.Institut für PathologieUniversitätsklinikum EssenEssenDeutschland

Personalised recommendations